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1 INTRODUCTION 
Separation processes leading to highly pure substances are essential to the 
pharmaceutical, biotechnology and food industries. The starting material is usually the 
effluent from fermentation, consisting ofa desired product or products along with many 
impurities. The bioseparation steps needed to isolate the desired products are referred to 
as downstream processing. These steps involve purification by various methods from 
filtration, centrifugation and extraction, to electrophoresis and chromatography. New 
separation technologies are constantly appearing (Gupta and Mattiasson 1994), but due 
to its high separation efficiency, high performance liquid chromatography (HPLC) 
remains the method of choice for the separations of peptides and proteins requiring a 
high degree of purity. Therapeutics, for instance, require 99.997% purity (Wheelwright 
1991) and proteins used in research and development require purity between 95-99.9% 
(Jungbauer 1993). 
Such purifies are routinely achieved by liquid chromatography. In general terms, 
chromatographic separations depend on the differential migration of sample 
components, or "adsorbates," flowing through a column made ofa stationary phase (SP) 
and mobile phase (MP). The SP is a particulate "adsorbent" and the MP or "eluent" is a 
fluid that moves or "elutes" through the column. As the sample components are eluted 
at different rates through the column, they become separated and emerge at different 
times. 2 
Ion exchange (IEX), reversed phase (RP), hydrophobic interaction (HIC), 
normal phase, affinity/biospecific interactions, and size exclusion (SEC) are all different 
modes of interactions available for chromatographic separations. IEX separations are 
based on the binding of electrically charged adsorbates onto an ion-exchange SP. RP 
and HIC rely on the hydrophobicities of the eluting adsorbates to the hydrophobic 
stationary phase, whereby the less polar adsorbates will bind more strongly to the SP, 
and the more polar adsorbates will prefer the MP. RP and HIC differ in their degree of 
hydrophobicity, with the RP stationary phase having a greater hydrophobicity. Normal 
phase chromatography uses a polar stationary phase and a non-polar eluent. SEC is 
based on size only and is less effective at separatingvery similar complex biomolecules 
than any of the other modes. Affinity chromatography depends on using specific 
interactions between the desired products and the SP. 
1.1 Chromatographic theory 
Although the theory of chromatography applies to many other types of 
chromatography (gas chromatography, liquid-liquid chromatography, etc.), the 
following discussion will deal in terms of solid-liquid chromatography. 
Chromatography is modeled according to two fundamental assumptions, representing 
the thermodynamic effects of the components binding to the SP, and the kinetic effects 
that are due to the diffusion and mass transfer of the components through the column. 3 
The thermodynamic effects can be linear or non-linear. In a linear system, 
adsorbates do not interact with each other because their concentrations are so low that 
they bind according to the linear portion of their adsorption isotherm. An adsorption 
isotherm represents the concentration distribution of the component molecules between 
the solid and liquid phases. Non-linearity occurs when adsorbate concentrations are 
sufficiently high that competition for binding sites occur, giving rise to a non-linear 
adsorption isotherm. If kinetic effects, such as peak bandspreading, are not present, the 
chromatographic system is said to be ideal, otherwise it is non-ideal. A chromatographic 
system can then be conveniently classified into four types of models: linear and ideal, 
linear and non-ideal, non-linear and ideal, and non-linear and non-ideal (Table 1.1). 
Ideal chromatography  Non-ideal chromatography 
Linear  too idealized, not much use  Analytical chromatography 
isotherm 
Non- Good first approximation of  General case, very complex, 
linear  preparative chromatography  numerical solutions needed 
isotherm 
Table 1.1: Classification of chromatographic models. Ideal, non-ideal, linear, non-linear 
definitions. 
Linear, ideal chromatographic models are too simplified to be of much use. 
Extensive and well-understood models under linear, non-ideal conditions are used in the 
field of analytical chromatography. Analytical separations deal with components under 
low concentrations and therefore only consider bandspreading effects. Complete 4 
solutions can be obtained for linear, non-ideal separations, using either a rate model or a 
plate model (Kucera 1965). 
In preparative runs, the non-linearity by itself can cause tailing and peak shape 
distortions. For instance, when bandspreading effects are minor, such as in the case of 
well-packed columns using very small particles, the shape distortions are dependent 
primarily on the curvature of the adsorption isotherms of all the molecules present in the 
run (which can also include the organic solvent adsorption isotherm itself). 
Non-linear, ideal chromatographic models are a good first approximation of 
preparative runs, and have worked well for predicting preparative runs of small 
molecules such as alcohols (El Fallah and Guiochon 1991).  A review of solutions to the 
ideal model of chromatography is given by Guiochon and Golshan-Shirazi 1994. Non-
ideal, non-linear models, on the other hand, are very complex. Various models have 
been summarized by Velayudhan et al. (1992). 
Numerical models are needed for the study of preparative non-linear, non-ideal 
chromatography. In modeling a non-linear, non-ideal chromatographic system, the mass 
balance, non-linearity and non-ideality must be satisfied. The mass balance of the jth 
component in a column is represented by (Velayudhan et al. 1995, Ruthven and Ching 
1993): 
Sc  8q .  . +u 
.
+ =0
St  8x St 5 
where Sc /& is the accumulation in the mobile phase, 089 45t is the accumulation in the 
stationary phase, and vocicir is the convective flow. The non-linearity is represented by 
an adsorption isotherm: 
q* = f  (1.2) 72) 
where q. is the concentration of the ith component in the SP at equilibrium, and depends 
in principle on the mobile-phase concentrations of all the components. 
To take into account the non-ideality of a system, the semi-ideal 
chromatographic model can be used, such as the "lumped" model (Velayudhan et al. 
1995). This model accounts for all non-idealities by representing the overall 
bandspreading through a lumped mass-transfer coefficient: 
(1.3) q; =kmr,j(qjqj)
St 
where qi is the/
h 
adsorbate concentration in the SP at any time t q.. is the/
h adsorbate 
concentration in the SP at equilibrium, and kali is the overall mass transfer coefficient 
accounting for all non-ideal phenomena. The kw; term is obtained from a lumped 
equation on the bandspreading term. Non-ideal chromatographic behavior involve peak 
broadening processes, such as pore diffusion (internal mass transfer, Ci), film mass 
transfer (external mass transfer, C1), binding/sorption kinetics (Ck), axial dispersion 
(A/v) and eddy diffusion (B). The overall bandspreading is given by the sum of all these 
effects, as expressed in the Van Deemter equation. The VanDeemter equation relates 
the band spreading to the theoretical plate height of the column(H), which is a measure 
of a column's bandspreading efficiency: 6 
H.
A  (1.4) +B+C,v+Cfv+Ckv 
In a lumped model, the plate height is "lumped" into a single value representative of all 
the bandspreading effects. All bandspreading effects (H) are lumped into a single mass 
transfer effect: 
Hiwnped  CiunipedV  (1.5) 
where Clumped is related to the overall mass transfer effects kw. The models are 
summarized in Table 1.2. Neglecting the mass transfer effect gives back the equilibrium 
model of non-linear chromatography. 
Equilibrium Model  Lumped Non-Equilibrium 
Model 
Mass  Sc  Sc  Sq .  Sc. i  Sc, ' + v--L+ 0  ' =0  +v+ 0 gqi  =0 Balance  of  Sx  St  St 8x  St 
Isotherm  q* = fi(ci,c2,...,c) q* = fi(c1,c2,...,c)
J j  
Mass   qi = q
*  Sq *
J Transfer  i  =  kmrd.(q * q ) , . gt  J 
Table 1.2: Comparison of ideal and non-ideal chromatographic models. 
1.2 The single component Langmuir isotherm 
Adsorption isotherms are essential to predicting chromatographic behavior. The 
non-linearity of the isotherm has a major effect on the peak shape. Considering the 7 
single component isotherm (SCI), whether the isotherm is linear, concave down, or  
concave up has an effect on the shape of the chromatographic peak. A linear isotherm  
gives a Gaussian chromatographic peak, concave down isotherms tend to front and  
convex isotherms tail (Figure 1.1). 
Cs 
CM 
Figure 1.1: Plot of concave, linear and convex isotherms. 
One of the simplest adsorption isotherms (see equation 1.2) is the Langmuir 
form. If we consider the stationary phase of a reversed-phase system as composed of 
homogeneous hydrophobic patches, then the single "patches" of hydrophobicity on a 
single molecule will bind to the free "patches" on the stationary phase: 
c+I  q  (1.6) 
where c is the concentration of the adsorbates in the MP and q the concentration of 
adsorbates in the SP, and I the concentration of free patches on the SP. If A is the total 8 
concentration of patches (known as the saturation capacity) on the SP, and K is the 
equilibrium constant, then  
I = A q  (1.7)  
K=  (1.8)  =  c I  c(A q) 
Therefore, the single component isotherm is  
A K c  (1.9)  
q = 1+ K c 
which gives an explicit expression of q in terms of c. If we remain in the linear portion 
of the isotherm, then K*c << 1 and therefore qz-A*K*c. K is the Henry's law constant, 
and is the slope of the isotherm at c=0. Under conditions where the saturation capacities 
(A) of the SCI of each components are identical (A1= A2 = A3 = ...), then the isotherm 
can be extended to multiple components (Antia and Horvath 1989, Quinones and 
Guiochon 1996): 
A jKiCi  (1.10) 
qi =  m 
1 -FEIC,c, 
This form is also used even when Ai* A2 # A3 #..., because of its simplicity. The 
"modulator" can play a significant role on the isotherm in overloaded gradient elution. 
In IEX, the modulator is a salt, and in RP, the modulator is an organic solvent such as 
acetonitrile or methanol. The modulator is used to adjust, or "modulate", the polarity of 
the mobile phase in RP. Just as salt modulators influence the distribution of proteins 
(Kaltenbrunner 1996), the organic modulator has an effect on the adsorbate binding to 9 
the RP stationary phase and must be taken into account in the isotherm (Velayudhan and 
Ladisch 1991). The organic modulator can be considered to be one of the binding 
adsorbates considered in equation 1.10. The Langmuir isotherm for Xphe and Xtrp 
accounting for the modulator is (Antia and Horvath 1989): 
-3_cm a e P  C p P qp  
1+ bpe-sPcm cp + bTe-sTc" cr  
a Te-sTcm cT  
qT =  -s C  
1 + b e- s TC m CP  + bTe  P  cT P 
where CM represents the modulator concentration, qp and qr the stationary phase 
concentration of the Xphe and Xtrp adsorbates respectively, ap, al; by and br the 
corresponding isotherm parameters, and s is the slope of the modulator k' as a function 
of the modulator concentration. The exponential terms account for the logarithmic 
binding behavior of the modulator in reversed-phase chromatography (Snyder 1980). 
1.3 Analytical vs. preparative chromatography 
Depending on the purpose of separation, analytical or preparative 
chromatography is used. Analytical chromatography is used for sample identification 
and quantitation. It requires as many sample solutes as possible be separated. In 
contrast, maximum recovery of a solute or solutes for a given purity is desired in 
preparative chromatography (Guiochon 1986). As a result the desired solute(s) are 
isolated in relatively large amounts and at a high purity. One fundamental goal of 10 
preparative chromatography is to optimize productivity. The productivity relates the 
throughput (amount of the desired adsorbate purified at a given purity) to the time it 
took to complete the purification, and to the amount of stationary phase material that 
was used in the process. 
When designing large-scale production, preparative chromatography is initially 
attempted under low loadings on analytical-scale columns. Then once throughput and 
other relevant parameters have been optimized, columns are then simply scaled up. It is 
therefore crucial to optimize the productivity at the analytical scale. Scale-up theory 
using the plate model and the rate model of chromatography have been widely 
examined (Knox and Pyper 1986, Velayudhan and Ladisch 1993, Whitley et al. 1993, 
Heuer et al. 1996). 
Present preparative chromatographic purification, however,  is typically performed under 
linear isotherm conditions, and as a result the stationary and mobile phases, which 
contribute the major separation costs (Felinger and Guiochon 1994), are not being used 
to their fullest potential (Ruthven and Ching 1993, Hodges et al. 1993). For instance, 
the preparative purification ofa binary system is done by optimizing their analytical 
separations and then increasing the injected quantity until right before the two adsorbate 
peaks begin to overlap (Colin 1993, Knox and Pyper 1986). This type of separation does 
not take advantage of competitive interactions that can occur at higher loads (Colin 
1993). With this type of separation, the sample loading (how much can be put onto the 
column) being used is so low that the different adsorbates in the sample bind to the 
adsorbent independently from one another as well as from the other adsorbate species. 11 
If the sample load is increased until the adsorbates begin to compete against one 
another for sites, the binding ceases to be linear, and operation conditions become 
complex. However, throughput can be significantly improved and these added 
complications can be overcome with further understanding of these non-linear 
processes. 
1.4 Gradient elution under non-linear conditions 
Preparative improvements of purification using non-linear adsorption is 
dependent on the type of operational mode that is being used. Operational modes 
include isocratic elution, gradient and stepwise elution,  frontal chromatography and 
displacement chromatography. The operational modes considered here are isocratic, 
gradient and step-wise elution. In isocratic elution, the concentration of the modulator 
in the MP remains constant throughout therun. In gradient elution the concentration of 
the modulator in the MP is increased with time. As the modulator concentration 
increases, polarity of the MP decreases, and the adsorbates are less likely to bind to the 
SP and elute faster. Stepwise gradient elution is when the modulator concentration is 
abruptly increased to a higher modulator level using a step. Thereafter the modulator is 
kept constant as in isocratic elution. 
Gradients are beneficial in preparative purifications as a result of several effects: 
(1) Peak focusing effect: Because of the initial low modulator concentration, the feed 
components bind strongly to the inlet of the column. However, the increase in 12 
modulator concentration eventually cause the adsorbates to elute earlier than if it was 
kept at isocratic conditions. This means that the adsorbates elute with a smaller k' (less 
retained). The decreased retention reduces the band broadening. This usually results in 
the concentration of the eluting adsorbate peaks (Snyder and Kirkland 1979). In 
addition, a decrease in k' means that the equilibrium distribution coefficient (K) of the 
adsorbates decreases, and under overloaded conditions, nonlinear adsorbate isotherms 
then become linear (Figure 1.2), a phenomenon known as gradient linearization (Frey 
1990). 
(2) Self and mutual interference effect: Under high feed concentration, there may not be 
enough binding sites available on the stationary phase. As a result, the adsorbates 
compete for sites, and the peak shape is dependent on the non-linearity of the 
component's isotherm. In the presence of other eluting component species, the 
competitive binding gives rise to multicomponent isotherms, and the resulting effect is 
the mutual interference effect (Velayudhan 1995). 
(3) Band compression effect: As the gradient increases, the peak is sharpened because 
the adsorbates at the tailing end find themselves under higher modulator concentrations 
causing them to elute faster, catching up to the adsorbates at the front end which are at 
lower modulator concentration. As a result, a chromatographic peak which would 
normally tail under isocratic conditions may become Gaussian in a gradient (Snyder and 
Kirkland 1979). 
Using gradient elution, peaks can be concentrated to more than its original 
concentration in the feed sample (Snyder et al. 1989). The solutes collected as a result 13 
are enriched. In general, preparative chromatography in isocratic conditions are 
performed under linear conditions. These chromatographic separations are simpler to 
deal with, and linear isocratic elution has been extensively studied. Retention 
mechanisms of isocratic elution are well understood (Martin 1988, Snyder and Kirkland 
1979) and scale up of optimized isocratic systems have been done using various models 
(Gibbs and Lightfoot 1986, Ladisch and Velayudhan  1995).  
Improvements in HPLC technology have led to shorter separation times,  
improvements in gradient manipulations, more reproducible results and greater  
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Figure 1.2: Gradient linearization with increasing modulator concentration (CM). 14 
efficiency (e.g., higher plate count). Improvements in HPLC peptide separations have 
been done by changing particles (e.g., particle size, pore diameter, bonded-phase 
composition), or by changing mobile phase composition, therefore improving band 
shape, adsorbate recovery and resolution (Stadalius et al. 1984). Therefore, the 
instrumental improvements and technological innovations of HPLC have improved 
biomolecule purification. 
However, fundamentally, preparative purification under linear conditions is very 
inefficient, as mentioned before. Preparative separations are commonly done in industry 
by increasing the concentrations of the mixtures to be purified, until the lowest 
acceptable resolution is reached. The system is then scaled-upby running larger feed 
volumes into proportionally larger columns. Although this type of purification method 
makes it relatively easy to scale up to production levels, which may mean gram 
quantities of materials being produced, the column isnot being overloaded because the 
adsorbate conditions are not high enough to produce appreciable isotherm non-
linearities. As a result, the concentration of adsorbates obtained relative to the amount 
of solvent being used is very low (Felinger and Guiochon 1994, Colin 1993). 
1.5 Reversed phase chromatography 
Of particular interest is the RP mode because of its common usage by research 
and industry and its effectiveness in separating similar compounds. RP is efficient at 
separating complex molecules; for instance, RP chromatography can separate 15 
diastereomeric peptides that contain more than 10 amino acid residues (El Rassi et al. 
1990). RP also has excellent reproducibility (Dolan et al. 1987). However, RP is not 
frequently used for larger protein purification as denaturation problems occur (El Rassi 
et al. 1990). Although there are attempts to model the effects of denaturation (Whitley et 
al. 1994) and there are sometimes ways to avoid denaturation such as starting at low 
solvent strength (Cox 1993), proteins are most often purified using ion-exchange 
chromatography (IEX), while peptides are usually separated by reversed-phase 
chromatography (RP). However, RP was used to purify proteins by intentionally 
denaturing and renaturing it (Knuth and Burgess 1987). Nevertheless, in general, RP 
should be used for separating polypeptides with molecular weights < 10000 (Welinder 
et al. 1991). 
A RP system utilizes the hydrophobic nature of the adsorbates as a basis for 
separation. The SP is composed of a matrix with carbon chain ligands attached. 
Ligands chains of 18 carbons in length attached to silica based particles are commonly 
used. The MP is composed of a mixture of water and an organic solvent such as 
methanol or acetonitrile. As the adsorbates are injected into the RP column, the less 
polar (more hydrophobic) adsorbates will bind to the SP, and the more polar adsorbates 
will prefer the MP and elute first. That is why an organic (non-polar) solvent such as 
methanol or acetonitrile is added to reduce the polarity of the MP, in turn reducing the 
retention of adsorbates, which may otherwise be irreversiblyadsorbed. 
Reversed-phase HPLC is used with for the purification of many compounds. 
Peptides used in the study of learning and memory have been preparatively purified 16 
using RP-HPLC (Gasc 1982). Industrial production of the antibiotic cephalosporin is 
well developed (Kodama et al. 1995). Preparative liquid chromatography has also been 
used for quality assurance for impurity determination such as impurities in arbidol and 
SI-5 drugs (Miller and Bergeron 1994). Hormones are commonly separated using RP-
HPLC (Welinder et al. 1991). The high purity that can be obtained by RP-HPLC makes 
it suitable for cell membrane molecules such as the lipid ganglioside(Menzeleev et al. 
1994). Other substances purified by RP-HPLC include sugars, antibiotics, lipids, amino 
acids, peptides, and enzymes. 
1.6 Loading and throughput 
Preparative purification is used in laboratory scale purification of peptides for 
further lab scale experimental uses and in industrial scale up for commercialization 
purposes. Sample loads are typically around 0.001 to 0.1 gram of sample/gram of 
packing (McDonald and Bidlingmeyer 1987). A measure of the productivity of a 
purification process is therefore essential. The measure of productivity depends on the 
purity desired. At 98% and 95% purity, the productivities (P) are defined as 
M98%  m95%  (1.12)  
P98% =  or P 95°A  =  
tcyc  * VSP  tcyc  * VSP  
where m98% is the mass collected at 98% purity and the m95% is the mass collected at 
95% purity, tcy, is the cycle time or the time that it takes to purify the sample plus the 
time it takes to regenerate the column for the next cycle, and Vsp is the volume of the 17 
stationary phase of the column. In determining the cycle time, 20 minutes was chosen as 
the column regeneration time. It was assumed that one regeneration was needed for each 
gradient elution, and two isocratic runs could be performed before regeneration of the 
column was needed; therefore 20 minutes was added to the cycle time for gradient runs 
and 10 minutes was added for isocratic runs. A list of some other examples of purified 
biological products with their estimated productivities (according to equ. 1.12) is given 
in Table 1.3. 
1.7 Model mixture: chemotactic peptides 
An analytical scale RP column was preparatively used under overloaded 
gradient conditions for peptide purification. The chemotactic dipeptides N-formyl-met-
trp, N-formyl-met-phe, N-formyl-met-val and N-formyl-met-ala were selected for their 
similarity in structure and their biological uses, such as in the study of chemotaxis in 
bacteria. Escherichia coli and Salmonella typhimurium are known to form regular 
patterns when grown. This occurs because these bacteriaare able to excrete a chemical 
attractant, and aggregate according to the gradient of that attractant (Budrene and Berg 
1995). These chemotactic substances have been identified as peptides (Marasco et al. 
1984). 
Of the four peptides selected, N-formyl-met-trp and N-formyl-met-phe were 
eventually selected for their close separation factor (tested to be o1.2, see section 
3.2.1). Preparative runs were performed with both ACN and Me0H as modulators and 18 
the results of isocratic and gradient elution productivities were compared. Limiting 
conditions turned out to be the solubility of the N-formyl-met-phe peptide and 
selectivity reversal in methanol conditions. The effect of feed conditions on the 
chromatograms were also examined. 19 
Reference  product  column  approx. approx. approx. 
dimensions 
L x D 
(cm x cm) 
Vsp 
(ml) 
icy, 
(min) 
nip 
(mg) 
])=-mpicycVsp) 
(mg/hrm1) 
Wolfe et al. 1984  human  6.6  17.56  50  0.01  0.00068 
interleukin -2  x 
2.2 
Welinder et al. 1987  human growth  25.0  1.26  80  0.016  0.0096 
hormone  x 
0.4 
Kodama et al. 1995  cephalosporin C  15.0  2.97  150  0.38  0.051 
x 
0.6 
Kalman et al.1996  phe-pro isomers  25.0  1.66  30  1.0  1.0 
x 
0.46 
tyr-pro-phe isomers  25.0  1.73  35  1.0  1.0 
x 
0.47 
Wu and Greenbladt 1995  lysozyme  25.0  1.66  30  2.0  2.4 
x 
0.46 
ribonuclease  25.0  1.66  30  2.0  2.4 
x 
0.46 
BSA  25.0  1.66  30  2.0  2.4 
x 
0.46 
Menzeleev et al. 1994  ganglioside proteins  25.0  35.97  25  3.1  0.21 
x 
2.14 
Minkiewicz et al. 1996  bovine K-casein  25.0  47.12  50  8.0  0.20 
x 
2 
Erhard et al. 1987  leukotriene B4  25.0  35.30  40  33.8  1.4 
x 
2.12 
Kroeff et al. 1989  insulin  15.0  7.29  260  153.0  4.8 
x 
0.94 
Feng et al. 1996  a-amylase  25.0  57.02  110  200.0  1.9 
x 
2.2 
Edwards et al. 1996  microcystins  15.0  530.14  50  415.0  0.94 
x 
7.5 
Bishop et al. 1980  tetrapeptide  30.0  535.87  40  1000.0  2.8 
x 
5.7 
Table 1.3: Typical productivities in bioproduct purification using RP-HPLC. 20 
2 MATERIALS AND METHODS  
2.1 Equipments and protocol 
The adsorbates considered are small peptides which have a relevant biological 
purpose and activity. The following bioactive peptides were purchased from Sigma (St. 
Louis, MO): 
N-formyl-methionyl-alanine (X-ala) 
N-formyl-methionyl-valine(X-val) 
N-formyl-methionyl-phenylalanine (X-phe) 
N-formyl-methionyl-tryptophan (X-trp) 
Preparative injections were performed using a Waters 600 pump (Milford, MA). 
The procedure is described in Figure 2.1. Briefly, it involved injecting a sample mixture 
into the column, running an isocratic or gradient elution, then manually collecting 
fractions at 15 or 30 second intervals. These fractions were then re-injected under 
analytical conditions, using a Waters 717plus autosampler, so that concentrations could 
be obtained using a previously generated calibration curve (see Figure 2.2). 
Concentrations were often so high that they saturated the UV detector. Thus, the 
fractions had to be collected, diluted and then re-run analytically. 21 
Injection of preparative feed 
(0.2-3.0m1, 0.5-5mg/m1) 
Isocratic or gradient run 
(Novapak column) 
I 
Detection by UV 
(214nm) 
1 
Fractions collected 
(15 or 30 sec intervals) 
I 
Fractions re-injected onto analytical column  
using autosampler  
(20[11, Novapak)  
I 
Each fraction quantified using calibration curve 
I 
Preparative chromatogram obtained 
Figure 2.1: Schematic of preparative run and analysis of fractions. 
The Waters (Milford, MA) millenium chromatography software was used 
throughout. All adsorbates were detected with a Waters (Milford, MA) 486 UV 
absorbance spectrophotometer at 214 nm. Three columns were used: 
1. A Waters (Milford, MA) Novapak C18 reversed-phase column 150 x 3.9 mm I.D., 
60A pores with 41.1m average particle diameterwas used for preparative injections and 
analyses of fractions of the dipeptides using acetonitrileas the organic modifier. 22 
2. A second Waters (Milford, MA) Novapak C18 reversed-phase column 150 x 3.9 mm 
I.D., 60A pores with 41..tm average particle diameter was used for preparative 
injections of the dipeptides using methanol as the organic modifier. 
The preparative runs were done at room temperature. The Novapak C-18 
columns were run at lml/min flow rate. 
Adsorbate concentrations for the binary mixtures of dipeptides in the feed varied 
from 0.4 to 1 mg/ml (see results section). Feed volumes ranged from 0.5m1 to 3.0m1. 
The X-phe and X-trp dipeptides were calibrated using the Novapak C18 at 20% 
acetonitrile isocratic conditions at lml/min flow rate and 20111 injection volume. The 
calibration curve ranged in concentration from 0.01mg/m1 to 0.38mg/m1 (Figure 2.2). 
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Figure 2.2: Calibration curve for X '-phe and X-trp. 23 
All solvents were mixed with 0.1% trifluoroacetic acid (TFA) except for the 
studies done on the effect of feed (see section 3.2.3). Sequanal grade TFA was obtained 
from Pierce (Rockford, IL). HPLC grade acetonitrile was purchased from E.M. Science 
(Gibston, NJ) and the water was distilled-deionized using the Corning Megapure 
System (Corning, NY). A mixture of monobasic sodium phosphate and dibasic sodium 
phosphate (Mallinckrodt, Paris, KY), adjusted to pH=7 was used as buffers. 
The sodium phosphate buffer solution was made as follows: 
(1) One solution of 10mM monobasic and another solution of 10mM dibasic solutions 
were made from powder: 
(a) dibasic (pH>7) solution: 1.42g of Na2HPO4 was added to 1L of distilled 
water (141.96g/mol Na2HPO4 0.01M = 1.42g/L). 
(b) monobasic (pH>7) solution: 1.38g of NaH2PO4 was added to 1L of distilled 
water (1.37.99g/mol NaH2PO4 0.01M = 1.38g/L). 
(2) Then using a pH meter (Corning, NY) the monobasic sodium phosphate was 
gradually added to the dibasic sodium phosphate solution, until the pH = 7, while 
maintaining a constant stirring. 24 
2.2 Adsorbate retention factors and phase ratio 
The adsorbate retention factor k' is obtained from: 
(2.1) k'= 
Vo 
where VR is the adsorbate residence volume, and Vo is the column void volume,or the 
volume that is required to elute the adsorbate if it is unretained. An adsorbate retention 
plot is obtained by calculating the various k' for different concentrations oforganic 
solvents, from VR obtained experimentally. VR is obtained by measuring the retention 
times (tR) of the solutes at various modulator concentrations (VR=tR). Obtaining the 
void volume Vo is described below. 
For the Novapak column used for the preparative runs, Vo can simply be 
calculated by measuring the mass and weight of the column, and using the result: 
m= w, + pV0  (2.2) 
where m is the mass measured on the column experimentally at a certain concentration 
of modulator, we is the weight of the column and p is the density of the solvent mixture 
at that modulator concentration. Since the density of the solvent mixtures at different 
concentrations of modulators is known, several measurements can be made for a more 
accurate result (Table 2.1). The modulator used here was Me0H. 
The linear regression (Figure 2.3) gave: 
m = 1.19p+ 62.7  (2.3) 
Therefore, the void volume is simply the slope, Vo  = 1.19 ml. 25 
Concentration Me0H  Mass of column m (g)  density of Me0H p (g/m1).-
(%v/v) 
10  63.85  .982 
30  63.8  .952 
50  63.77  .916 
70  63.72  .872 
90  63.65  .820 
*Perry and Green 1985 
Table 2.1: Measurements of column and modulator parameters for void volume 
calculations. 
63.9 
63.85  O 
63.8  'O .; 
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Figure 2.3: Regression plot of column mass and density of mixture. 26 
The phase ratio (0) is the ratio of the volume of SP to the volume of MP. If we 
assume that all pores are accessible, then the void volume equals the mobile phase 
volume (V0 = Vmp), and the phase ratio is: 
VSP  V SP  (2.4) 
Vidp  Vo 
where Vsp is the stationary phase volume and VMP is the mobile phase volume. The 
volume of the stationary phase is simply the difference between the empty column 
volume and the void volume of the column: 
(2.5) 
The phase ratio is therefore: 
1.79m1 - 1.19ml  (2.6) = 050 
1.19m/ 
2.3 Measurement of adsorption isotherms 
To determine the adsorption isotherms of the solutes X-phe and X-trp, the 
Elution by Characteristic point (ECP) method was used. This method uses data points 
from the trailing edge of an individual component peak to generate isotherm data. The 
ECP method is known to be sufficiently accurate for chromatographic systems with a 
plate count greater than 100 (Guan et al. 1994). Assuming ideal chromatographic 
conditions, it is derived that (Conder and Young 1979): 
u0  (2.7)
(dr ), = 
dq 1+ 0
dc 27 
u0 is the void velocity, 0 is the phase ratio and q is the adsorbed concentration. 
Given that zic=(dx/dt), is the adsorbate velocity corresponding to any 
concentration c, and that this velocity is constant throughout the column for the trailing 
edge of any peak, this equation can be rewritten in terms of time, 
dq)	  (2.8)  t  t (1 + 0
dc  
and in terms of volume, 
dq	  (2.9)  =V0(1+ 0)
dc  
Using equation 2.4, we have finally:  
dq	  (2.10)  Vc =V0+ V sp 
dc  
Then q is obtained, by integrating dq 
dc 
,  
dq  vc  Vo  fVo(c)Vo	  (2.11) ,  
q  =  ac  
dc  Vsp  Vsp  
Assuming a single component isotherm, q can be obtained from a preparative single 
component chromatographic run. The procedure involve the following steps (Figure 
2.4):  
1) Pick a concentration, e.g. c1, and find the corresponding Va. 
2) Vsp is known: Vsp = Vec  V, = Vec  Vo where Vec is the empty column volume. 
dq
3) Find  since Vc  V0 , and Vsp are known.
dc 
,  
4) Integrate	 dq  to get q.
dc 28 
C(L,t) 
V 
Vel 
Figure 2.4: Chromatograph of a single component preparative run. 
But we need to take into account the feed volume (\Ti). The feed volume is given by 
Vim; = rini F.  (2.12) 
V..  (2.13) 
Vo (c)  Vo 
= f  2 dc 
Vsp 
This integration can be calculated numerically. A QBASIC program is given in 
appendix A. Isotherm results are given in sections 3.2.4 and 3.3.2. 29 
2.4 Peptide solubility 
The solubility of the dipeptides were low in both acetonitrile and methanol; 
peptide insolubility in organics is not uncommon (Menzeleev et al. 1994). Solubility 
can frequently be a problem in preparative purifications, due to the high loading 
conditions. This is a common problem in industry. As mentioned by (Porsch 1994), 
solubility can be crucial in preparative L.C.: "it determines the possible loading, 
performance, throughput and concentration of collected fractions". In general, 
insolubility should be avoided. Therefore, all the preparative conditions were chosen 
based on this limitation. 
Depending on the organic solvent used, the solubility limits varied. It was found 
that the solubility of the peptides depended on the method used to purify it. For 
instance, Xphe seem to not dissolve in TFA. If, however, the peptides were already 
dissolved in the solvent, then there was a tendency to remain in solution despite adding 
TFA after, although the dissolution may not necessarily be permanent. Therefore 
various "solubilizing methods" were used. The methods are described in Table 2.2, and 
an example for making a 2mg/m1 of Xphe and Xtrp solution in 40/60 ACN/buffer 
solution is included (Table 2.3). 
In the example in Table 2.3, only method B could solubilize 2mg/m1 of Xphe 
and 2mg/m1 of Xtrp in 40/60 ACN/buffer. Sections 3.2.3 and 3.3.1 describe the results 
of the solubility tests. 30 
No TFA  With TFA 
Method A: Add solutes to mixture*  Method C: Add solutes to mixture; 
then add TFA 
Method B: Add solutes to organic; then add buffer  Method D: Add solutes to organic; 
then add buffer; 
then add TFA 
Method E: Add solutes to mixture already 
containing TFA 
*mixture=organic+(buffer or water) 
Table 2.2: Methods used to try to solubilize the peptides in either Me0H or ACN, and 
H2O or sodium phosphate buffer. 
Method  To make a 2mg/m1 solution in 40/60 ACN/buffer 
solution: 
A  1. prepare a 40/60 ACN/buffer solution in a 4m1 vial 
2. add 8mg of P and T 
3. stir until clear 
B  1. prepare 1.6ml of ACN in a 4m1 vial 
2. add 8mg of P and T 
3. stir for 1/2 hour at least (does not have to clear) 
4. add 2.4 ml buffer 
5. stir until clear 
C  1. prepare 1.6m1 of ACN 
2. add 8mg of P and T 
3. stir for at least 1/2 hour at least (does not have to 
clear) 
4. add 2.4 ml buffer 
5. add 4n1 of TFA 
D  1. prepare a 4m1, 40/60 ACN/buffer 
2. add 8mg of P and T 
3. stir for at least 1/2 hour at least (does not have to 
clear) 
4. add 4p1 of TFA 
5. stir until clear 
E  1. prepare a 4m1, 40/60 ACN/buffer with 4W TFA 
solution 
2. add 8mg of P and T 
3. stir until clear 
Table 2.3: Preparation of solutions using the methods A-E listed in Table 2.2. 31 
Although TFA may reduce solubility, it is needed in the samples and throughout 
the column. Reversed phase without TFA results in long tailing and very weak 
retention. The effect becomes dramatic under preparative conditions: a preparative run 
where no TFA was present throughout gave mixed peaks eluting at nearly to (Figure 
2.5), but an identical run with TFA throughout gave peaks that were separated and 
eluted much later (Figure 2.6). TFA is commonly used in reversed-phase columns for its 
ability to narrow peaks and improve retention. TFA lowers pH (Table 2.4); at 0.1% 
TFA the pH lowers to 2.7 in a sodium buffer solution, and 2.2 in water solution. Ion 
pairing with the protein or peptide forming an increased hydrophobicity (decreasing 
solubility) is one possible reason for the improved retention and selectivity 
(Wheelwright 1991). However, TFA is also known to have secondary effects whose 
exact mechanisms on the column are not completely understood (Bennet et al. 1981). 
% TFA in 10mM sodium  pH  Solvent mixture  pH 
phosphate buffer 
0.1  2.7  NaHPO4 buffer  7.0 
0.075  3.3  NaHPO4 buffer + 0.1% TFA  2.7 
0.05  5.6  H2O (distilled)  6.5 
<0.03  6.9  H2O (DD) + 0.1% TFA  2.2 
Table 2.4: pH of solvents under various conditions, with and without TFA. 32 
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Figure 2.5: 10-40%ACN gradient in 20min. 10mM sodium phosphate buffer throughout 
(no TFA). Feed: 0.5 mg/ml Xphe and 0.4 mg/nil X- trp, 1 ml volume. Novapak C-18 
(150 x 3.9mm I.D.), UV detection at 214nm. 
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Figure 2.6: Feed has 0.4mg/m1Xphe and 0.5mg/m1Xtrp, and TFA is present 
throughout. All other conditions same as Figure 2.5. 33 
3 RESULTS AND DISCUSSION  
3.1 Productivity and measure of error 
Productivities are used to compare the effectiveness of preparative 
chromatographic separations. From equation 1.12 (section 1.6), the productivity term 
was defined by the cycle time and by Vsp, the volume of the stationary phase of the 
column. V5 can be obtained from the empty column volume, 
Vsp = (1  6 i)*V  (3.1) 
where e, is the column total void fraction and lie, is the empty column volume (=L .nr2). 
For the Novapak C-18 column (150 x 3.9mm), V=1.79m1. Since the phase ratio is 
known (Section 2.2), we know et: 
(3.2) 
therefore, 
(3.3) 6 =
I
= 
I 
= 0.67 
1  1+0  1 +0.5 
and, 
Vsp = (1  0.67) * 1.79m1= 0.59m1  (3.4) 
Productivity depends on the measurement of the mass collected. Therefore, in 
comparing productivities, it is important to have an idea of the extent of the error 
involved in measuring mass. Figures 3.1 and 3.2 give the error distributions for the 34 
masurements of the mass balances for each peptides for the runs where the masses were 
accounted for. For the X-phe peptide, of the preparative chromatographic mass 
measurements described in the figure, 4 measurements are outside the 15% error range, 
meaning that within 15%, the data is representative of 91% (42/46=91%) of all the 
samples. For the X-trp peptide, 7 measurements have a greater error than 20%, 
therefore the measurements with less than 20% represent 87% (48/55=87%) of all the 
data. This means that any results obtained which vary within 15% from one another for 
X-'phe and within 20% for X -trp are considered to be insignificant changes, while any 
results with a difference greater than 15% for X-phe and 20% for X-trp will be 
considered a significant change. 
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Figure 3.1: Error distribution of the X-phe peptide mass balances. 35 
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Figure 3.2: Error distribution on the X-trp peptide mass balances. 
3.2 ACN conditions 
3.2.1 Initial runs 
Of the four peptides examined, X-phe and X-trp were considered interesting 
peptides to separate, in the sense of having a low separation factor yet eluting within a 
reasonable amount of time (Figure 3.3). X-phe and X-trp dipeptides have very similar 
retention. RP-HPLC is often used for very difficult separations. While slightly higher 
for preparative chromatography, in analytical chromatography a difficult separation is 36 
considered to have a separation factor (a) of 1.1 or less. For instance, a=1.2 for Xphe 
and Xtrp at 20% isocratic ACN (Table 3.1). Xala elutes too fast (k'=0.554) while the 
Xval is not close enough to Xphe (a=4.0) or Xtrp (a=4.9) to be a system we want to 
consider. Therefore Xphe and Xtrp was used for preliminary preparative injections. 
Xala  Xval  Xphe  Xtrp  
k' at 20% ACN  0.554  1.38  5.47  6.76  
Xphe -- Xtrp  Xval -- Xphe  Xval Xtrp 
a at 20% isocratic  1.2	  4.0  4.9 
ACN 
Table 3.1: k' and a values for 20% isocratic ACN. 
X-phe LI 
0	  X-trp 
o	  X-ala 
X-val X :. 
fit X-trp 
fit X-ala 
- - - fit X-val 
5  15 25 35 45 55 65 75  85 
ACN Concentration (v/v%) 
Figure 3.3: Adsorbate retention on Novapak C-18 column under Acetonitrile conditions. 37 
A 20 minute ACN gradient from 10% to 40% was used for initial overloaded 
trials. This gradient was chosen because all solutes will have eluted by the time 40% 
ACN concentration is reached, and 20 minutes is a reasonable separation. A 0.5mg/m1 
feed concentration of Xphe and X trp each in 0.5m1 was tried. The result is shown in 
Figure 3.4. The peaks are mixed and relatively Gaussian, and resemble an isocratic 
elution, considering that the initial feed solution of 0.5 mg/ml diluted to about a peak of 
0.15mg/ml. This indicates that additional mass can be added, since overloaded 
conditions were not reached (and higher loadings might improve the separation, due to 
nonlinear competitive effects). However increasing the concentration caused a "dip" in 
the phenylalanine peak, as shown in Figure 3.5. Xtrp increased in concentration. The 
increase in concentration is probably due to the gradient compression effect under 
overloaded conditions. Increasing the volume instead of themass (Figure 3.6) shows a 
similar dip but no concentration of the Xtrp. Doubling both the Xtrpand Xphe 
results in the Xphe being pushed forward as all binding sites seemed to be taken up. 
The dip however still remains. 
A complication arose with these runs. The initial feed solutions were made in 
buffer solution containing no TFA, and so the initial column solvent conditions differed 
to the feed solvent composition. Under large injection volumes, this can affect peak 
shape. It was discovered later that Xphe is very insoluble in ACN/buffer/TFA, and 
therefore, the Xphe entered into conditions which were unfavorable in terms of 
solubility. This may have caused some of the Xphe to precipitate onto the SP at the 38 
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Figure 3.4: ACN gradient 10-40% in 20min. 0.5 mg/ml X.phe and 0.5mg/m1Xtrp in 
0.5m1 feed volume. 0.1% TFA and buffer throughout. Flow rate lml/min. Novapak C-
18 column (150 x 3.9 mm I.D.). UV detection at 214nm. 
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Figure 3.5: 1.0mg/m1Xphe and 1.0mg/m1Xtrp, 0.5m1 volume. All other conditions 
are identical to Figure 3.4. 39 
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Figure 3.6: 0.5 mg/m1 X .phe and Xtrp, 1.0 ml volume. All other conditions are 
identical to Figure 3.4. 
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Figure 3.7: 1.0mg/m1 Xphe and Xtrp, 1.0 ml volume. All other conditions are 
identical to Figure 3.4 
25 40 
inlet of the column and caused some X-phe to elute ahead. The long band in Figure 3.7 
is due to this high concentration causing the X-phe to elute almost unretained due to 
competition for binding sites. As the dipeptides elute, at a certain point, the X-phe 
resolubilizes either because the concentration decreased enough, or the insoluble X-phe 
became more soluble in the presence of X-trp and caused the X-trpto be pulled ahead. 
In Figure 3.5 the two dipeptides are well separated despite the dip.  The presence of the 
dip in the X-phe peak suggests that X-phe binds at two different retentions. It is 
reasonable to think that it is due to the insolubility of X-phe. If the X-phe is more 
soluble in the presence of X-trp, for instance, some of the X-phe attempts to remain 
with the X-trp while the rest elutes quickly, possibly because this portion was pushed 
ahead by the higher organic concentration in the feed. Increasing the volume and/or the 
concentration further, causes the X-trp to be moved ahead noticeably, while the X-phe 
elutes almost unretained. It is as if the X-trp is being pulled by the X-phe. The X-phe, 
being in such unfavorable conditions, tries to elute as fast as possible. 
The effect of the dip could not be examined any further. The conditions of the 
column changed (see section 3.2.4), and these dips could not be reproduced. 
Nevertheless, insolubility may be a cause of the dips. These results are interesting as 
they show that insolubility of solutes can be a great limitation when using HPLC. These 
runs were therefore discontinued, and attempts were made thereafter to obtain higher 
peptide solubilities. 41 
3.2.2 Effect of feed conditions 
At high injections of feed volume, the sample solvent and mobile phase should 
be identical to that of the initial column condition; otherwise the peaks deform and may 
split, and peak efficiency is reduced, affecting the separation (Porsch 1993). 
Nevertheless, a differing sample solvent condition tends to be the case in practice; to 
have as high a solubility as possible frequently requires the feed samples be in different 
conditions from that of the column mobile phase. If the organic modifier in the feed 
sample is less than that of the mobile phase, then enrichment can occur (Werkhoven et 
al. 1981). This is similar to using a stepwise elution. In stepwise elution, the feed 
components are injected in low modulator concentration, and after a short time, the 
modulator concentration is increased in a step. The lower isocratic condition causes the 
components to be strongly bound to the column. The step increase in modulator 
suddenly makes the peptides elute almost unretained, and band broadening is decreased, 
and peaks are sharpened. 
A typical preparative trace is shown in Figure 3.8. At 214nm under high 
loadings, the Xphe and X --trp peaks saturate, while the presence of impurities are 
present. In 40/60/0.1 ACN/buffer/TFA a higher concentration could be obtained for the 
peptide mixture than in 10/90/0.1 ACN/buffer/TFA (see section 3.2.3). In addition, 
samples with no TFA were more soluble. Therefore, the possibility of using feed 
conditions that are different than initial starting column conditions was examined. A 
0.5mg/m1 of the dipeptide mixture in 40/60 ACN/buffer was injected into a 10-40% 
ACN gradient (Figure 3.9). Comparing to a 0.5mg,/m1 solution in 10/90 ACN/buffer 42 
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Figure 3.8: Trace of preparative chromatographic run, in which the column and the feed 
have identical conditions (10/90/0.1 ACN/buffer/TFA). The conditions are 10-40% 
ACN gradient in 20min in 10mM sodium phosphate buffer, 0.1% TFA throughout. 
0.5mg/m1Xphe and 0.5mg/m1Xtrp. 1 ml feed volume. Flow rate lml/min. Novapak 
C-18 column (150 x 3.9mm I.D.). UV detection at 214nm. The plateau is due to the 
saturation of the UV detector. 
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Figure 3.9: Trace of preparative chromatographic run, in which the feed is in 
40/60ACN/buffer. All other conditions are identical to Figure 3.8. 43 
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Figure 3.10: Trace of preparative chromatographic run, in which the column is pre-
equilibrated in 10/90/0.1 ACN/buffer/TFA, but the feed is in 10/90 ACN/buffer (no 
TFA). All other conditions are identical to Figure 3.8. 
1.6 
1.4 
1.2 
1 
0.8  -X phe
-X trp
0.6 
0.4 
0.2 
1 1, 
0  5  10  15 
Time (min) 
Figure 3.11: Preparative chromatographic run identical to Figure 3.8, with fraction 
collection. The column and the feed are in identical conditions. 
20 44 
with an identical gradient (Figure 3.8), the difference is remarkable. Having a higher 
organic feed condition caused part of the feeds to elute unretained, causing an unusually 
large "split" in the chromatographic peaks. 
A similar effect occurs if TFA is removed from the feed (Figure 3.10) but 
keeping the organic equal to the column condition. A lack of TFA in the feed acts like 
having a greater organic concentration in the feed. Fractions were collected for these 
preparative runs. The chromatogram obtained from the fraction collection seems to 
indicate that Xphe is particularly sensitive to such a change in condition; most of the 
Xphe peak elutes at to (compare Figures 3.11 and 3.12). A possible explanation is that 
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Figure 3.12: Preparative chromatographic run identical to Figure 3.10, with fraction 
collection. Column is pre-equilibrated with 10/90/0.1 ACN/buffer/TFA but the feed is 
in 10/90 ACN/buffer (no TFA). 45 
a local "no-TFA" region moves through the column causing the relatively insoluble 
Xphe to want to remain in that region, and therefore move with it, ahead of other 
solutes not in that region, and a deformed peak results. Having both a 40% ACN feed 
that does not contain TFA results in an extreme condition where both peptide peaks 
split into two regions (Figure 3.13). 
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Figure 3.13: Preparative chromatographic run identical to Figure 3.12, except the feed is 
in 40/60 ACN/buffer (no TFA). 
3.2.3 Peptide solubility 
The initial runs have shown the necessity of having the initial column condition 
equal to the feed conditions, and therefore the need to maximize solubility at low 46 
mobile phase modulator concentration. The X-phe and X-trp need to be in organic 
modifier concentrations of around 10-20% to have the same conditions as that of the 
column initial conditions. Solubility estimation of these molecules was done 
qualitatively; that is, the solution was considered soluble if no precipitate was observed. 
Feed Component  Concentration  Solvent condition  Solubility 
mg/ml  (method) 
(1)  X-phe  0.75  15/85 ACN/buffer  S 
(A) 
X-phe  0.75  15/85/0.1 ACN/buffer/TFA  I 
X-phe  1.0 
(E) 
15/85 ACN/buffer  S 
(B) 
(2)  X-trp  1.0  15/85 ACN/buffer  S 
(A) 
X-trp  1.0  15/85/0.1 ACN/buffer/TFA  S 
(D) 
(3)  X-phe  0.75  15/85/0.1 ACN/buffer/TFA  I 
X-phe + X-trp  0.75 
(D) 
15/85/0.1 ACN/buffer/TFA  S 
(D) 
(4)  X-phe  0.5  15/85/0.1 ACN/buffer/TFA  I 
(E) 
X-phe  0.5  15/85/0.1 ACN/buffer/TFA  S 
(D) 
(5)  X-phe + X-trp  0.5  10/90/0.1 ACN/buffer/TFA  S 
(E) 
X-phe + X-trp  0.5  10/90/0.1 ACN/H20  I 
(A) 
(6)  X-phe + X-trp  1.5  40/60/0.1 ACN/buffer/TFA  S 
(C) 
X-phe + X-trp  1.5  40/60 ACN/H20  I 
(A) 
Table 3.2: Solubility of feeds in ACN/buffer (S: soluble, I: insoluble). 47 
In trying to solubilize these dipeptides, various methods (A, B, C, D and E) were used 
as described in section 2.4. The methods C, D and E correspond to samples that 
contained TFA. 
Several observations were made about the Xphe and Xtrp peptides (Table  
3.2):  
(1) There are some indications that suggest that Xphe by itself is insoluble in 
0.1%TFA. For instance, at 15/85 ACN/buffer, 0.75 mg/ml could be obtained without 
TFA using method A, but not with TFA present using method E. Even  1mg/m1 could be 
obtained with method B when no TFA is present. 
(2) On the other hand, Xtrp seemed unaffected by the TFA; lmg/m1 could be obtained 
in 15/85 ACN/buffer and 15/85/0.1 ACN/buffer/TFA. The Xtrp was more soluble than 
Xphe for all conditions used in the runs. The limitation on solubility was therefore 
primarily due to Xphe. 
(3) Xphe seemed to solubilized in the presence of Xtrp, but not by itself. 0.75mg/m1 
of Xphe alone would not solubilize in 15/85/0.1 ACN/buffer/TFA, but would 
solubilize if Xtrp was present. 
(4) An interesting observation was that adding the Xphe in the organic solvent first 
seemed to improve its solubility; 0.5mg/m1 of Xphe using method E would not 
solubilize, but would solubilize using method D. 
(5) The buffer was also compared to water. 0.5mg/m1 of Xphe and Xtrp could be 
obtained in 10/90/0.1 ACN/buffer/TFA, but could not be obtained in 10/90 ACN/H20 
even though TFA was not even present in the latter case. 48 
(6) At higher organic concentration of 40/60/0.1 ACN/H20, 1.5mg/m1 X --phe and Xtrp 
solution was insoluble. Up to 1.5mg/m1 of the dipeptide mixtures could be obtained at 
40/60/0.1 ACN/buffer/TFA. 
To obtain an isotherm for X .phe, a high concentration is needed under a low 
organic solvent concentration. 0.5mg/m1 in 15/85/0.1 ACN/buffer/TFA (method C or D) 
shown in Table 3.2 was used for the isotherm determination. It should be noted that 
adding TFA at the end (methods C or D) worked for 0.5mg/m1 of Xphe for a limited 
time. Stirring the sample for a long period of time (e.g. 2 hours) would eventually cause 
the peptide to fall out of solution. Solubilizing the peptide initially in no TFA conditions 
apparently allowed it to enter into solution, and eventually the added TFA would cause 
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Figure 3.14: Solubility of Xphe (P) and X.trp (T) inACN/water solutions, using 
methods A and B (without TFA) 49 
it to precipitate. This "metastable" state can be used to advantage. In preparative 
chromatography, if the sample in question can remain soluble long enough to be used 
during the chromatographic purification, after the fractions are collected, the metastable 
peptides can either be immediately diluted or the conditions changed so as to prevent it 
from precipitating. This was done for some of the preparative runs (see section 3.2.6). 
Up to 1 mg/m1 in 40/60 ACN/buffer had been used for the runs where the feed 
differed from the column conditions (see section 3.2.2). Since 0.75mg/m1 of X-phe and 
0.75mg/m1X-trp mixture solubilized at 10/90 ACN/buffer, these feed concentrations 
were used for the preparative runs (section 3.2.5 and 3.2.6). 
A summary of all the solubilities done for ACN/buffer and ACN/H20 is shown 
in Figures 3.14 and 3.15 (a and b). 
3.2.4 Adsorbate retention and adsorption isotherms 
After the preliminary runs were done, the column used under ACN/buffer 
conditions was tested again for the retention of X-phe and X-trp. The column was 
found to have deteriorated over time. Comparing Figure 3.17 with Figure 3.3 (section 
3.2.4), retention time decreased. At 20% isocratic ACN/buffer, the capacity factors 
decreased by about 30% (Table 3.3). 50 
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Figure 3.15: Solubility of X-phe (P) and X---trp (T) in ACN/buffer solutions, using 
different methods (A-E): (a) without TFA, (b) with 0.1% TFA 51 
X--phe  Xtrp 
k' of 6/27/95 (20-80 ACN-buffer)  5.5  6.8 
k' of 9/13/96 (20-80 ACN-buffer)  4.2  5.2 
Table 3.3: Retention factors k' in 20% isocratic ACN on Novapak column; comparison 
of retention times, and of their changes over time. 
The retentions of the peptides do not vary greatly using H2O as solvent or using 
buffer conditions (Figure 3.16 and Figure 3.17). Since a concentration of 0.75mg/m1 
could be obtained in 10/90/0.1 ACN/buffer/TFA, preparative runs were done under 
those conditions. Several observations can be made from figure 3.17: 1) The plot is non-
linear. In reversed phase, the logarithmic adsorbate retention factor is commonly 
assumed to depend linearly on the organic modifier concentration, e.g. in the linear 
solvent strength (LSS) theory (Snyder 1980)  . The LSS theory states that under reversed 
phase conditions, k' varies exponentially with time. This condition requires that k' be 
exponentially dependent on the modulator concentration and that the gradient be linear 
at the inlet of the column. The k' dependence on the modulator concentration means that 
k' = Ae-ac"  (3.1) 
Taking the logarithm on both sides, 
In k'= ln A BCm  (3.2) 52 
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Figure 3.16: Adsorbate Retention factors in ACN/H20. 
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Figure 3.17: Adsorbate Retention factors in ACN/buffer. 53 
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Figure 3.18: Isotherms of Xphe and Xtrp obtained by using the "Elution by 
Characteristic Point" method. These were obtained from the isocratic runs on Figure 
3.19 and 3.20. 
We see that this relationship is linear. However, the experimental data for the system we 
are using for Xphe and Xtrp are not linear (Figure 3.17); the datawas fitted to a 
quadratic functionf(x)=Ax2+Bx+C. Therefore, the LSS theory does not hold. This has 
implications for the computer simulations of this system. The LSS theory allows one to 
predict the retention of the peptides given the gradient change and isocratic k'. 
However, according to (Snyder 1986), the non-linearity of in k' vs. CM can be 
approximated as linear over a range of 1<ki<10. Further work by Glajch et al. (1986), 
show that "non-linearity of log k' vs.  plots can be treated by LSS theory as well as the 54 
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Figure 3.19: Isocratic run for isotherm determination.  15% isocratic ACN, buffer and 
0.1% TFA throughout. 0.9mg/m1X-Irp, 2.4m1 volume. Novapak C-18 (150 x 3.9 mm 
I.D.). UV detection at 214nm. 
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Figure 3.20: Isocratic run for isotherm determination. 0.5mg/m1X-phe in 2.4m1
volume. All other conditions are identical to Figure 3.18. 55 
case of linear plots". This is reasonable so long as only an approximation is required. 
However, for simulation purposes, an exact fit is required. 
(2) The curves are very close: the plot shows that the X-phe and X-tip compounds are 
very closely related, and therefore very difficult to separate. sr)1.1 is considered a 
difficult separation; for preparative separations the value is generally higher. At 15% 
ACN, a=14.8/11.3=1.3, but at 20% ACN, a----4.1/5.3=0.7.3) The curves converge: As 
the modulator concentration is increased, the curves become narrower and converge. 
That means the higher the organic concentration the more difficult the separation. 
The above observations depict a realistic situation in peptide purifications. These 
limitations make purification extremely expensive. However, such a situation can be 
improved under conditions of high loading. 
The adsorption isotherm were obtained using the ECP method (see section 2.3) 
for individual preparative runs of X-trp and X-phe in 15/85/0.1 ACN/buffer/TFA 
conditions (Figure 3.18). The highest concentration obtainable for the single component 
runs for X-trp was 0.9mg/m1 (Figure 3.19) and 0.5mg/m1 for X-phe (Figure 3.20). The 
adsorption isotherms show the beginnings of non-linearity. 
A Langmuir equation did not fit the data well on Figure 3.18 so a quadratic fit 
was used. The quadratic gives a good fit because the isotherm is very shallow, and an 
approximation can be made on the Langmuir isotherm. The Langmuir isotherm is given 
by: 
ac  (3.3) q =  = ac(l+bc)-1
1+ bc 56 
Considering the binomial expansion, and since the isotherm curve is shallow, b c<1, 
1  (3.4) =1 be + b2  +...= 1 be
1+ bc 
q = ac(1  bc) = ac  bc2 = quadratic  (3.5) 
Therefore a quadratic is a good representation of the isotherm behavior of these peptides 
and could be used for simulation purposes. 
3.2.5 Isocratic elution 
Using 0.75mg/m1 of Xphe and 0.75mg/m1 of Xtrp in 20/80/0.1 
ACN/buffer/TFA mixture an isocratic 20/80/0.1 ACN/buffer/TFA was done (Figure 
3.21). It is known that k'r.:55 (Figure 3.17, section 3.2.4) for the dipeptides in 10% 
isocratic ACN, and  5 for peptides in 20% isocratic. Therefore a 20% isocratic ACN 
is a reasonable starting point; the resulting peaks are just beginning to mix (Figure 
3.21). There seems to be very little peak tailing, and because of the short time the 
peptides have spent in the column, there has not been too much peak dilution. Any 
further increase in volume for instance from lml to 2.4m1 only increases the mixing of 
the two compounds (Figure 3.22). 
This isocratic run can be further optimized by improving the resolution of the 
peaks by lowering the organic concentration to 15%. However, lowering the 
concentration too much will result in too long a retention (k'255), which will decrease 
the productivity. At 15% ACN, the runs are very well separated under similar 57 
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Figure 3.21: Isocratic 20/80/0.1 ACN/buffer/TFA. 0.75mg/m1Xphe and Xtrp in 1 ml 
feed volume. Fractions were collected at 1/2 minute intervals. Novapak C-18 RP 
column (150 x 3.9mm I.D.). UV detection at 214nm. 
0.9 
0.8 
0.7  fl 
0.6 
0.5 
-X phe
0.4  ----X tip 
0.3 
0.2 
0.1 
0 
0 2  4 6  8  10  12 
Time (min) 
Figure 3.22: Identical to Figure 3.21 except for 2.4 ml feed volume. 58 
conditions to the 20% ACN run Figure 3.23). The 0.5mg/m1 feed concentration was 
used because it was made by diluting a 0.75mg/m1 at 20/80/0.1 ACN/buffer/TFA. 
However, a higher concentration (0.75mg/m1) was eventually found to be possible at 
15/85/0.1 ACN/buffer/TFA. Increasing the volume further to 2.4m1 was possible 
(Figure 3.24) as well as 3m1 (Figure 3.25). At 3m1 volume the X-phe is beginning to 
significantly tail into the X-trp. 
The increased mixing by volume overloading under 20% isocratic ACN resulted 
in no increase in the amount of peptides purified. The yields decreased dramatically 
(90% to 30% for X-phe and 86% to 14% for X-trp, for instance) and the amount 
purified remained about the same for X-phe and decreases for X-trp (Table 3.4). As 
expected, the decrease in the modulator to 15% isocratic ACN resulted in 100% yield, 
but an increase to 3m1 reduces the yield to 94%. The peptides are being affected by the 
increase in the volume as the X-phe begins to tail into the X-trp peak. Nevertheless, a 
large amount is produced. Due to the solubility limitation (the X-phe peak is 
concentrated beyond its solubility limit), no further increase in volume was considered. 
The productivities of these isocratic runs varied from 1.32 mg/ml to 6.6mg/ml. 
In calculating the productivity, the tom,, given in equation 3.1 defines a cycle time. The 
cycle time refers to the time it takes for the column to have completed the whole 
purification cycle. This is the time which includes the preparative purification step (tpur), 
plus the regeneration time (tg): 
toy = tp, + ceg  (3.3) 59 
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Figure 3.23: Isocratic 15/85/0.1 ACN/buffer/TFA. 0.5mg/m1Xphe and 0.5mg/m1 
Xtrp in lml feed volume. All other conditions same as Figure 3.21. 
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Figure 3.24: Isocratic 15/85/0.1 ACN/buffer/TFA. 0.75mg/m1Xphe and 0.75mg/m1 
Xtrp in 2.4 ml feed volume. All other conditions same as Figure 3.23. 60 
The regeneration time refers to increasing the organic modifier concentration to a high 
level (e.g., 80% ACN), to clean out the column by eluting all impurities that may be 
remaining. In gradient elution, a regeneration is performed after each preparative run. 
In an isocratic runs, it will be assumed that two runs can be performed before a 
regeneration step is needed. A regeneration time of 20 minutes was taken, meaning that 
for isocratic elution the t  tp, + 10 min, while the gradient would be tcy, = tp,. + 20 
min. 
The optimized 15/85/0.1 ACN/buffer/TFA isocratic gave a productivity of 
around 6.6mg/mlhr for Xphe and up to 7.2mg/mlhr for X --trp (Table 3.4). The 
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Figure 3.25: Isocratic 15/85/0.1 ACN/buffer/TFA. 0.75mg/m1 Xphe and 0.75mg/m1 
Xtrp in 3.0 ml feed volume. All other conditions same Figure 3.24. X-phe  X-trp 
98% purity  95% purity  98% purity  95% purity
Description  yield  Enrich.  Product.  yield  Enrich.  Product.  yield  Enrich.  Product.  yield  Enrich.  Product. 
( %)  mg/mlhr  (%)  mg/mlhr  (%)  mg/mlhr  (%)  mg/mlhr
isocratic 20%  90  0.65  3.54  86  0.65  3.54  90  0.37  3.48  86  0.37  3.48 0.7mg/m1 X -phe  
0.7mg/m1 X-trp  
lml volume  
isocratic 20%  30  0.77  2.7   14  0.88  4.56  51  0.19  1.32  14  0.19  1.32 0.8mg/m1 X-phe 
0.8mg/m1X-trp 
2.4m1 volume 
isocratic 15%  100  0.24  1.92  100  0.24  1.92  100  0.22  1.92  100  0.22  1.92 0.6mg/m1X-phe 
0.6mg/m1X-trp 
1.0m1 volume 
isocratic 15%  97  0.64  5.52  93  0.64  5.52  97  0.33  5.22  100  0.33  5.52 0.7mg/m1X-phe 
0.7mg/m1X-trp 
2.4m1 volume 
isocratic 15%  94  0.98  6.6  78  0.98  7.2  94  0.36  6.6  94  0.39  6.6 0.7mg/m1 X-phe 
0.7mg/m1X-trp 
3m1 volume 
Table 3.4: Isocratic yields, enrichments (enrich.) and productivities (product.) of X --phe and X-trp, for 98% and 95% purity. 62 
enrichment factor is the ratio between the average concentration of the collected 
fractions by the average concentration in the feed. The isocratic runs are not able to 
concentrate the feed (El Fallah and Guiochon 1991), thus the enrichment factor remains 
below 1. Although at the inlet of the column, the process of feed introduction serves to 
concentrate Xphe initially, it eventually becomes diluted below the average feed 
sample concentration. The generally poor enrichment factor for the Xtrp is due to its 
tailing. Collecting all of the tail results in a low average concentration of the region 
collected. 
3.2.6 Gradient Elution 
Before considering gradient purification, a note should be made concerning 
gradient delay. In a chromatographic system, the solvents used to change the gradient 
(in this case the ACN and buffer) pass through two pumps and a gradient former. Then, 
before the gradient reaches the beginning of the column, it must first pass through 
tubing that connects the pump to the autosampler, then through tubing that connects the 
autosampler to the sample loop where the feed samples were injected. Therefore, there 
is a delay between the time the feed samples are injected into the column and the time 
the gradient is able to reach the column inlet. The peptides remain under isocratic 
conditions for the duration of the gradient delay. This delay must be taken into account 
when considering the gradient separations. In the isocratic case, because the organic 
modifier concentration remains constant at all time, there is no time delay. 63 
Finding the gradient delay was done as follows. After 5 minutes of equilibration, 
a 0.5 minute pulse of 5% acetone was programmed from the solvent reservoir (Figure 
3.26). Therefore, after 5 minutes of equilibration, the acetone pulse must travel through 
the tubing described above, and then through the column void volume until it is detected 
by UV. The time (tn) that it takes for the pulse to emerge from the column and be 
detected by UV is the total of the time delay (tddy), the time it spent in the column 
unretained (t0=1.2 min), and the equilibration time before the pulse was injected (5 
minutes). 
tP = t_ +12 min+ 5 min  (3.4) 
In addition, the peak detected by UV is measured in terms of its center of mass. 
Therefore the center of mass of the pulse must be considered. A 0.5 minute pulse has a 
center of mass of 0.25 minutes. Therefore, 
tp = tdday +1.2 min+ 5 min+ 0.25 min  (3.5) 
And finally, the time delay can be calculated, 
tdelay = tP  5 min-12 min 025 min  (3.6) 
The tR is the time of the unretained pulse. tR was 11.8 minutes, which gives a 
delay time of 5.4 minutes. Therefore, a delay of 5.4 minutes is expected for the 
modulator gradient to reach the adsorbates at the inlet of the column. 
A gradient of 10 to 40% ACN, in 20 minutes (1.5%/min gradient steepness) was 
done using 0.5 mg/ml of X 'phe and X 'trp in lml volume (Figure 3.27). The 
enrichment factor was 1, meaning that the peaks did not dilute and instead remained at 64 
their same concentration. The separation is also complete with 100% yield. Yields, 
enrichments and productivities are summarized at the end of this section (Table 3.5). 
This suggests that a peak focusing effect due to the gradient is occurring. Under 
isocratic conditions, the elution of the components down the column causes the peak to 
broaden and therefore dilute. Since a gradient is being used the peaks did not dilute but 
remained at a relatively high concentration (identical to the feed in this case). To take 
advantage of this effect further, the concentration was increased to 0.75mg/mi and the 
volume to 2.4ml. The resulting preparative run was well separated (Figure 3.28). The 
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Figure 3.26: Measurement of the gradient delay time. A 0.5 minute pulse of 5% acetone 
was programmed at 5 minutes from the solvent reservoir to the detector. The Novapak 
C-18 column was pre-equilibrated to 50/50 ACN/H20 at lml/min. Detection was done 
at 254nm. 65 
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Figure 3.27: ACN gradient 10-40% in 20min, 0.4mg/m1Xphe and 0.5mg/m1 X- trp in 
lml feed volume. buffer and 0.1% TFA throughout. Novapak C-18 RP column (150 x 
3.9mm I.D.). Detected by 214nm UV. 
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Figure 3.28: ACN gradient 10-40% in 20min, 0.75 mg/ml Xphe and 0.75mg/m1 X- trp 
in 2.4 ml feed volume. All other conditions same as Figure 3.27. 
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Figure 3.29: ACN gradient 10-30% in 20min, 0.75 mg/ml Xphe and 0.75mg/m1Xtrp 
in 2.4 ml feed volume. All other conditions same as Figure 3.27. 
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Figure 3.30: ACN gradient 10-40% in 20min, 0.75 mg/ml Xphe and 0.75mg/m1Xtrp 
in 3.0 ml feed volume. All other conditions same as Figure 3.27. 67 
difference in the retention time at the front of the first peak is due to the increased feed 
volume (from lml to 2.4m1) that the gradient must travel through before reaching the 
inlet of the column. 
Sharp gradients improve the focusing effect. A steep slope of the gradient may 
therefore add to the focusing effect and cause the peaks to concentrate further. A 10 to 
30% ACN gradient shows that shallow gradient is less concentrated but better separated 
(Figure 3.29). The reason is that the gradient linearization of the isotherm is not as 
pronounced at 30% ACN. Nevertheless the yields remain identical, since all the 
peptides can be recovered. 
Increasing the volume even more to 3m1 brings the run to the limits of the 
peptide's solubility (Figure 3.30). Any further increase in volume is risking the 
precipitation of the Xphe peptide onto the column. Already, Xphe is being 
concentrated to 2.9mg/ml, which is not possible in ACN/buffer conditions. In fact, the 
concentrated X --phe fractions for this run crystallized a few minutes after they were 
collected. This suggests that the column SP was able to stabilize the Xphe, and prevent 
it from precipitating until after it came out of the column. The separation and yields are 
complete (100%). Some time after the collection of fractions, for the highly 
concentrated fractions, the peptides tended to crystallize. Apparently,the column was 
able to stabilize the peptides such that the fractions could concentrate up to 2mg/ml 
when inside the column, but began falling out of solution once out of the column. Once 
the separated peaks emerged, the fractions were therefore resolubilized in neutral pH 
(by adding buffer) and prevented from precipitating. 68 
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Figure 3.31: ACN 1/2min step gradient 10-15%, 0.75mg/m1Xphe and 0.75mg/m1 
Xtrp, 2.4 ml volume. All other conditions same as Figure 3.27. 
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Figure 3.32: Step gradient 10-15% in 0.5 minutes, 0.72mg/m1Xphe and 0.7mg/ml 
Xtrp. 3.0 ml volume. All other conditions same Figure 3.29. X-phe  X -trp 
98% purity  95% purity  98% purity  95% purity Description  yield  Enrich.  Product.  yield  Enrich.  Product.  yield  Enrich.  Product.  yield  Enrich.  Product. 
(%)  mg/mlhr  (%)  mg/mlhr  (%)  mg/mlhr  (%)  mg/mlhr 
gradient 10-40% in 20 min  100  1  1.02  100  1  1.02  100  0.64  1.62  100  0.64  1.62 0.4mg/m1 X -phe 
0.5 mg,/m1X-trp 
1 ml volume 
gradient 10-40% in 20min  99  1.9  5.34  100  1.9  5.34  99  2  4.62  100  2  4.62 0.7mg/m1X-phe 
0.7mg/m1X-trp 
2.4ml volume 
gradient 10-40% in 20 min  99  2.1  6.06  100  2.1  6.06  99  2.3  6.36  100  2.3  6.36 0.7mg/m1X-phe 
0.72mg/m1X-trp 
3m1 volume 
gradient 10-30% in 20 min  100  1.2  4.26  100  1.2  4.26  100  1.2  4.26  100  1.2  4.26 0.75mg/m1X-phe 
0.75mg/m1X-trp 
2.4m1 volume 
step gradient 10-15% in 0.5 min  100  0.51  3.72  100  0.46  3.72  100  0.46  3.72  100  0.46  3.72 0.72mg/m1 X -phe 
0.7mg/m1 X -trp 
2.4m1 volume 
step gradient 10-15% in 0.5 min  99  0.69  4.14  100  0.65  4.14  99  0.45  4.56  100  0.45  4.56 0.7mg/mIX-phe 
0.7mg/m1X-trp 
3m1 volume 
. 
Table 3.5: Gradient enrichments (enrich.) and productivities (product.) of X-phe and X-trp, for 98% and 95% purity. 70 
Even though the 15% isocratic run was at the limit of overlapping in 2.4m1 feed 
volume, increasing the feed volume to 3m1 improved productivity and enrichment, 
suggesting a displacement effect. A stepwise elution allows the peptides to retain for a 
longer period at the inlet of the column; once the modulator front reaches the inlet of the 
column, the peptides are force to elute without much retention, and less band 
broadening results. Applying this to the 15% isocratic preparative run (Figure 3.24), the 
separation can be improved. A 10-15% stepwise elution in halfa minute at the 
beginning of the elution run improved the separation of the two peaks (Figure 3.31). In 
contrast to the isocratic 15% run. The initial low 10% ACN condition at the inlet of the 
column may cause the X 'phe and X 'trp to compete for sites, with the Xphe being 
pushed ahead until the modulator front forced both peptides to elute with much less 
retention. The productivity and enrichments of the step elutions, however, are lower 
then for the isocratic runs (Table 3.6). This is probably due to the gradient delay. The 
gradient delay adds 5.4 minutes more to the half minute step. The peptides are therefore 
affected by the step increase in modulator after 5.9 minutes and not 0.5 minutes, as it 
takes that long for the gradient to reach the inlet of the column. Thus the peptides may 
already start to advance allowing bandspreading effects to occur, and the modulator 
front will not have as strong an impact. The gradient delay may also be the reason for 
the large difference in the breakthrough time of the 2.4m1 feed volume stepwise elution 
separation (Figure 3.31) compared to the 15% ACN isocratic elution (Figure 3.24). 
Nevertheless, the separation being better, the feed volume was again increased to 3m1 
(Figure 3.32). The increase in volume gave similar enrichment to the 15% isocratic run, 71 
but the productivity was still lower. The isocratic elution therefore turned out to be 
better than the stepwise elution runs (Table 3.6). 
Table 3.6 compares the preparative runs for isocratic, gradient and stepwise 
elution preparative runs. Although the isocratic runs seem to have greater or comparable 
productivity to the three other modes of operation, the linear gradient shows a clear 
enrichment of its peptides. For instance the 10-40% gradient at 2.4ml volume gives an 
enrichment of 1.9. However, interestingly, the 3m1 volume only gives an enrichment of 
X-phe  X-trp 
Description  98%  95%  98%  95% 
Enrich.  Product. Enrich.  Product.  Enrich.  Product.  Enrich.  Product. 
mg/ml-hr  mg/mlhr  mg/mlhr  mg/mlhr 
isocratic 15% 
0.7mg/m1X-phe 
0.8mg/m1X-trp 
3m1 volume 
0.98  6.6  0.98  7.2  0.36  6.6  0.39  6.6 
step gradient 10-15% 
in 0.5 min 
0.7mg/m1X-phe 
0.7mg/m1X-trp 
3m1 volume 
0.69  4.14  0.65  4.14  0.45  4.56  0.45  4.56 
gradient 10-40% 
in 20min 
0.7mg/m1X-phe 
0.7mg/m1 X-trp 
2.4m1 volume 
1.9  5.34  1.9  5.34  2  4.62  2  4.62 
gradient 10-40%  2.1  6.06  2.1  6.06  2.3  6.36  2.3  6.36 
in 20 min 
0.7mg/m1X-phe 
0.72mg/m1X-trp 
3m1 volume 
Table 3.6: Comparisons of the maximum productivities obtained using isocratic, step 
gradient and linear gradient elution. 72 
2.1. The increase in enrichment is small relative to the increase in the volume. This is a 
sign of the self interference effect. At such high loading, gradient linearization is no 
longer valid, and the peak focusing effect is overcome by non-linear peptide 
interactions. That is, adsorbate behavior occurs in the non-linear region of their SCI. 
Although ideally one would want to use the focusing effect to achieve tremendously 
high enrichments, in this case, because of the solubility problems of the Xphe, the self-
interference of the peptides was beneficial to this separation. Nevertheless, it is clear 
that the isocratic runs reached their limits of productivity; the gradients, were it not for 
the solubility limitation, would have been able to give even higher productivities. In 
addition, these productivities are much greater than the productivities normally obtained 
in literature discussed in the introduction (Table 1.3, section 1.7). 
3.3 Methanol conditions 
3.3.1 Peptide solubility 
Having obtained an optimized gradient elution condition for ACN/buffer 
conditions, it is worth considering if productivity will improve under Me0H conditions, 
as changing the mobile phase modulator changes peptides solubilities and retentions. In 
an attempt to obtain as high a concentration of peptides as possible under methanol 
conditions, preliminary trials indicated that the peptides preferred Me0H to ACN: at 
100% ACN, not even a 0.5mg/m1 of Xphe and Xtrp mixture could be solubilized, but 73 
at 100% Me0H, 2mg/m1 of that mixture could be solubilized. Also, water was used 
rather than buffer because in the presence of TFA, lmg/m1 of dipeptide mixtures could 
be solubilized in 40/60/0.1 Me0H/H20/TFA, but 1 mg/ml could not be solubilized in 
40/60/0.1 Me0H/buffer/TFA. 
The elution strength of ACN is greater than that for Me0H; a 10% ACN 
isocratic is roughly equivalent to around 20% Me0H isocratic. This is because ACN is 
more hydrophobic than Me0H. A peptide mixture in 20/80/0.1 Me0H/H20/TFA is 
needed for preparative runs under Me0H conditions, as it is the lowest organic 
concentration necessary. At 20/80/0.1 Me0H/H20/TFA only 0.5mg/m1 mixture Xphe 
Feed Component  Concentration  Solvent Condition  Solubility 
mg/ml  (method) 
(1)  Xphe and Xtrp  0.5  100%ACN  I 
(A) 
Xphe and Xtrp  2  100% Me0H  S 
(A) 
(2)  Xphe and Xtrp  1  40/60 Me0H/buffer  I 
(C) 
Xphe and Xtrp  1  40/60/0.1 Me0H/H20/TFA  S 
(C) 
(3)  Xphe and Xtrp  0.5  20/80/0.1 Me0H/H20/TFA  S 
(C) 
Xphe and Xtrp  1  40/60/0.1 Me0H/H20/TFA  S 
(C) 
(4)  Xphe  0.6  30/70/0.1 Me0H/H20/TFA 
Xphe  0.5  30/70/0.1 Me0H/H20/TFA  S 
Xtrp  3  30/70/0.1 Me0H/H20/TFA  S 
Table 3.7: Solubilities in Me0H with comparison to ACN (S: soluble, I: insoluble). 
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Figure 3.33: Solubility of X-phe and X-trp in Me0H/H20 using methods A and B. 
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Figure 3.34: Solubility of X-phe and X -'trp in Me0H-H20 using methods C,D and E. 75 
and X -trp could be solubilized. However, at 40/60/0.1 Me0H/H20/TFA, a 1.0mg/m1 
mixture of X-phe and X-trp could be solubilized. Therefore,  the effects of using a feed 
condition at 40/60/0.1 Me0H/H20 were examined (section 3.3.2). 
Isotherms for the peptides under ACN conditions were done at 15% isocratic, 
which is roughly equivalent to a 30% isocratic Me0H run. Therefore, isotherms in 
30/70/0.1 Me0H/H20/TFA were done. At these conditions, 0.5mg/m1 of X-phe could 
be solubilized temporarily, but it would eventually fall out of solution after about an 
hour of stirring. This was probably due to the metastable state caused by the TFA as in 
the ACN case, as was discussed in section 3.2.3. The X-tp didnot have these 
solubility problems when solubilized by itself, and a concentration of 3mg/m1 could be 
obtained. Other solubility tests on the Me0H/H20 solvents are shown in Figure 3.33 
and 3.34. 
3.3.2 Selectivity reversal and adsorption isotherms 
Under Me0H/H20 conditions, adsorbate retention factors were obtained for 
X-phe and X-trp on the Novapak C18 column. Preparative runs were done over two 
different time periods. Over these two periods, the peptide retentions on the Novapak 
column decreased, and this must be taken into account when comparing runs (Figure 
3.35). The retention factors were linear (correlation factor not shown) under Me0H 
conditions as opposed to the ACN case (Section 3.2.1). Between 35 to 45% Me0H, the 
adsorbate retention lines of each peptides cross. This is known as "selectivity reversal". 76 
Selectivity reversal as a function of MP composition implies that the order of retention 
of the adsorbates changes as the MP composition varies. For instance the lesser retained 
component at low concentrations of organic solvent becomes the more strongly retained 
component at high organic solvent concentrations. The trends of the retentions of the 
component species can better be understood if we consider the separation factor 
(3.5) 
k' p 
Retention factors of two peptides can converge, diverge, remain parallel,  or have a 
selectivity reversal. Under acetonitrile conditions, no selectivity reversal was present; 
instead the lines converged. Convergence means that the k' of each components become 
closer (a becomes smaller) with increasing modulator concentration. Divergence occurs 
when the separation of the adsorbates increases with modulator concentration. Parallel 
retention means that the peptides elute in equal proportion throughout the modulator 
levels. With selectivity reversal, at modulator concentrations less than the selectivity 
cross point the k' converge (a < 1), and at higher modulator concentrations the k' 
diverge (a> 1)(Figure 3.36). 
The Xphe dipeptide could only be dissolved to a concentration 0.5mg/m1 in 
30/70/0.1 Me0H/H20/TFA conditions, and would precipitate at higher levels. The 
adsorption isotherm obtained using the ECP method (see section 2.3) shows that due to 
the low concentration of Xphe, only the linear portion of its isotherm could be 
obtained (Figure 3.37). The non-linearity can be seen with the Xtrp isotherm (Figure 
3.38). A quadratic equation was able to fit the X --trp isotherm very well. The k' 77 
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Figure 3.35: Adsorbate retention of Xphe and Xtrp on a Novapak C-18 column under 
methanol/water conditions, at two different time periods (3/4/96 and 12/11/96). 
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Figure 3.36: Separation factor variation with changing MP concentration due to the 
presence of selectivity reversal. (CM: modulator concentration). 78 
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Figure 3.37: Isotherm for Xphe on a Novapak C-18 RP column (150 x 3.9mm I.D.). 
The non-linear portion could not be reached because of the Xphe would precipitate at 
higher than 0.5mg/m1 concentration. 
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Figure 3.38: Isotherm for Xtrp on a Novapak C-18 RP column (150 x 3.9mm I.D.). 
This was done at two different times to see if any changes occurred over time. 79 
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Figure 3.39: Isocratic 30/70/0.1 Me0H/H20/TFA run for isotherm determination for 
Xphe. 0.5mg/m1Xphe in 2.4m1 volume. Novapak C-18 (150 x 3.9mm I.D.), UV 
detection at 214nm. 
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Figure 3.40: Isocratic run for isotherm determination for Xtrp. 3.0mg/m1Xtrp in
2.4m1 volume. All other conditions same as 3.37. 80 
dramatically changed between a the periods 3/4/96 and 12/11/96 (Figure 3.35); the 
column had been left in 0.1% TFA during storage, which had an effect on the column. 
Thereafter, the column conditions remained very stable as can be seen from the shapes 
of the isotherms: the X-trp isotherm was measured at a 6 month time interval and did 
not change over that time (Figure 3.36). The peptides are fairly strongly retained under 
the point of intersection of the selectivity reversal. The single component runs used to 
obtain the isotherms by the ECP calculations are shown in Figures 3.39 and 3.40. 
3.3.3 Initial runs 
X-phe and X-trp are poorly soluble under ACN conditions. Using 40/60 
Me0H/H20 conditions, however, 1 mg/ml concentrations of both peptides could be 
solubilized. The consequences of having a high level of Me0H in the feed were 
therefore examined. Using feed conditions that are different than the column did not 
work for the ACN case. Nevertheless, since the solvent strength of the Me0H is 
different to that of the ACN, the effect of the feed was examined. 
The ACN experiments have shown so far that a 20/80 ACN/buffer gives a 
reasonable capacity factor for X-phe and X-trp in the sense that they retain long 
enough to separate and yet elute close enough to remain a difficult separation (oc 
A 20% ACN is approximately equivalent to 30% Me0H. Therefore, as a first estimate, 
30% isocratic Me0H was used under similar volume and concentrations as the previous 
ACN runs that were done in 20% initial conditions. This is depicted in Figure 3.41. 81 
The chromatogram shows complete mixing. However, despite the 40% Me0H feed, the 
peptides are retained, and the long band eluting at to observed in the ACN case does not 
occur. According to adsorbate retention plot (corresponding to 3/4/96, Figure 3.35), at 
30% isocratic methanol, the k' of the two peptides are extremely close (oc-= 1.1), and as 
a result the peaks overlap at these high concentrations. 
To allow the adsorbates to retain longer and increase the k' so as to reduce 
mixing, the organic concentration is decreased. Figure 3.42 shows a run at a 25% 
isocratic methanol under similar conditions as the 30% run. This run shows the 
beginnings of a separation, but the mixing is still substantial. Decreasing the organic 
will further improve the separation. However, at 25% methanol, the k' are already 
0.4 
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Figure 3.41: Isocratic 30/70/0.1 Me0H/H20/TFA, lmg/m1Xphe and lmg/m1Xtrp, 
in 0.5ml feed volume, with 40/60/0.1 Me0H/H20/TFA feed. Novapak C-18 column 
(150x3.9mm I.D.), UV detection at 214nm. 82 
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Figure 3.42: Isocratic 25/75/0.1 Me0H/H20/TFA,  lmg/m1X-phe and X-trp in lml 
feed volume. All other conditions identical to Figure 3.41. 
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Figure 3.43: Linear gradient 25-40% Me0H in 25min, lmg/m1 X-phe and Img/m1 
X-trp in lml feed volume. All other conditions identical to Figure 3.39. 83 
greater than 10 (k'=11 for Xphe and k'=12 for Xtrp). Decreasing the methanol further 
may substantially increase the elution time. Therefore a gradient might turn out to 
produce a better separation at this point. 
In choosing a gradient, however, selectivity reversal must be taken into account. 
Selectivity reversal can cause the more retaining feed component peak to envelop the 
less retaining peak as a result of the reversal in retention at higher modulator levels, 
worsening the separation. Therefore, the gradient should be adjusted so that all the 
peptides will have eluted before the point of intersection of the selectivity reversal is 
reached. The point of intersection of selectivity under analytical conditions is around 
40% methanol according to Figure 3.35. At 40%, the k' of both compounds are around 
2. The peaks in the 25% isocratic were all eluted by 20 minutes. The peaks are 
completely mixed in a linear gradient from 25 to 40% methanol in at least 20 minutes 
with 1 mg /ml of dipeptides in 1 ml feed volume, although the peaks are slightly more 
concentrated than before, as expected from gradient elution (Figure 3.43). There is the 
presence of a "shallow region" at the front of the two peaks. These odd shapes present 
may be due to the large feed volume injection causing the 40% feed to briefly pull the 
peptides ahead at the inlet of the column. Reducing the volume injected to 0.5ml 
minimizes the impact of the 40% feed, and brings back the more familiar fronting peaks 
generally found in preparative chromatography (Figure 3.44). However, there is 
noticeable Xphe peak tailing into the Xtrp, and the separation remains poor. The 
tailing is probably due to selectivity reversal or the solubility of Xphe. 
The poor separation may be improved by using curved gradients. The HPLC 84 
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Figure 3.44: Linear gradient 25-40% Me0H in 20min, lmg/m1Xphe and lmg/m1 
Xtrp in 0.5m1 feed volume. All other conditions identical to Figure 3.41. 
0.3 
0.25 
0.2 
II
E
E  0.15 
o  X--phe
c X trp 0 
U 
0.1 
0.05 
0  
0 5   10  15 20 25 
Time (min) 
Figure 3.45: Curved 9 gradient 25-40% Me0H in 20min, 1mg/m1Xphe and 1 mg/ml 
Xtrp in 0.5 ml feed volume. All other conditions identical to Figure 3.41. 85 
instrument has settings available to perform curved gradients. A "curve 8" gradient 
remains fairly constant until a sharp increase in gradient occurs at about one third of the 
time given for the gradient. A curve "9" gradient begins curving sharply at about half 
way through the gradient time. 
The tailing in Figure 3.43 occurs between 13 to 17 minutes. The gradient should 
therefore begin around that time. A 25-40% gradient in 20 minutes using curve 9 
(Figure 3.45) has a sharp gradient increase occur after 15 minutes. The result is a slight 
improvement in the separation, probably due to a focusing effect on the Xphe peak. 
However, the gradient did not reduce the tailing of Xphe and Xtrp peaks. The curved 
gradient improved the separation by having the peptides initially bind at a lower 
modulator concentration, where they have the biggest k' difference until after around 15 
minutes where they are eluted with little binding because of the sharp curve 9 gradient. 
Increasing the time of the gradient to 30 minutes allows the peptides to remain in low 
modulator concentration for a longer period, and the separation improved (Figure 3.46). 
However,due to the increase in time, the peptides elute almost 10 minutes later. To try 
to gain time without losing separation resolution, a less curved gradient was tried. The 
curve 8 gradient improved retention time only slightly (Figure 3.47). The shallow 
region described earlier is present in the Xtrp peptide. The 40% feed probably caused 
the feeds to move ahead at the inlet of the column, preventing the focusing effect from 
having a full impact on Xtrp. 86 
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Figure 3.46: Curved 9 gradient 25-40% Me0H in 30min, img/m1 X-phe and 1 mg/ml 
X-trp in 0.5 ml feed volume. All other conditions identical to Figure 3.41. 
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Figure 3.47: Curved 8 gradient 25-40% Me0H in 30min, 1mg/m1 X-phe and 1mg,/m1 
X-trp in 0.5 ml feed volume. All other conditions are identical to Figure 3.41. 
0 87 
Because the elution time was high for the gradient runs, an isocratic 20% elution 
was attempted. This run did not have a large increase in the retention time compared to 
the gradients so far, yet the peaks seemed just as separated (Figure 3.48). The tailing 
however is longer, probably because of bandspreading. The front of the X-trp has a 
shallow region just as before. Doing a 20-40% Me0H curve 9 gradient in 20 minutes is 
able to concentrate the X-trp (Figure 3.47). In order to attempt to reduce the tailing, a 
gradient from 20-30% in 25 minutes, and kept constant at 30% thereafterwas done 
(Figure 3.50). This gradient would allow the separation to occur below the point of 
crossing of the selectivity reversal. The tailing remained throughout the different 
gradients and isocratic elutions attempted. This suggests that the tailing is caused more 
by the insolubility of the X-phe peptide rather than by the selectivity reversal. 
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Figure 3.48: Isocratic 20% Me0H. lmg/m1X-phe and lmg/m1 X -trp in 0.5 ml feed 
volume. All other conditions identical to Figure 3.41. 
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Figure 3.49: Curved 9 gradient 20-40% Me0H in 20min, 1 mg/m1 X-phe and 1 mg/ml 
X-trp in 1 ml feed volume. All other conditions identical to Figure 3.41. 
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Figure 3.50: Curved 9 gradient 20-30% Me0H in 25 min, 1 mg/ml X-phe and 1 mg/ml 
X-trp in 0.5 ml feed volume. All other conditions identical to Figure 3.41. X-Phe  X-trp  
98%  95%  98%  
Description  Yield  Enrich.  Product.  Yield  Enrich.   Product.  Yield  Enrich.  Product. 
(%)  mg/mlhr  (%)  mg/mlhr  (%)  mg/mlhr
20% isocratic  72 0.22  1.1  80  0.21  1.2  0  0  0  
lmg/m1 X-phe  
lmg/m1X-hp  
40% feed, 0.5 ml  
25-40% gradient  82  0.26  0.9  82  0.26  0.9  0   0 0 
30min, curve 9 
1.0mg/m1X-phe 
1.0mg/m1X-trp 
40% feed, 0.5m1 feed 
25-40% gradient  77  0.32  1.0  82 0.31  1.08  0  0  0  
30min, curve 8  
1.0mg/m1X-phe  
1.0mg/m1X-trp  
40% feed, 0.5m1 feed 
20-40% gradient  76  0.31  0.96  76  0.31 0.96  0  0  0 
20min, curve 9 
1.0mg/m1X-phe 
1.0mg/m1X-trp 
40% feed, 1.0m1 feed 
20-30-30% gradient  89  0.23  1.0  89  0.23  1.0 0 0  0 
25min, curve 9 
1.0mg/m1X-phe 
1.0mg/m1X-trp 
40% feed, 0.5m1 feed 
Table 3.8: Yields enrichments and productivities of selected preparative runs having 40% feed. 
95% 
Yield  Enrich.  Product. 
(%)  mg/mlhr 
0  0  0 
0  0  0 
0  0  0 
0  0  0 
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Figure 3.51: Linear Me0H gradient 20-30% in 25 min, then constant at 30% 0.4mg/m1 
X -.phe and lmg/m1 X-trp in 35% feed, 0.5m1 feed volume. All other conditions 
identical to Figure 3.41. 
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Figure 3.52: Linear Me0H gradient 20-30% in 25 min, then constant at 30% lmg/m1 
X-phe and 0.4mg/m1X-trp in 35% feed, 0.5m1 feed volume. All other conditions 
identical to Figure 3.41. 91 
The selectivity reversal places a greater limit on the productivities of the runs 
since gradients sharper than 40% Me0H could not be used. The productivities of these 
runs ranged about 0.01-0.02 mg/ml-hr. Interestingly, the isocratic gave a better 
productivity (Table 3.8). This may be due to the 40% feed preventing the focusing 
effect from taking full effect. The enrichments were slightly better for the sharp 25-40% 
Me0H gradients as well as the curve 8 gradient. Only the 20-30% gradient allowed the 
X-trp to be separated. 
The effect of the shallow region on the front of the peaks that has been observed 
throughout can better be observed when decreasing the concentration of one feed over 
the other. Taking a 1mg/m1 X-trp and 0.4mg/m1X-phe feed, the shallow region in the 
front of the X-trp peak can be observed clearly (Figure 3.51). This effect can be seen 
(Figure 3.52) by both peaks if a low X-trp concentration is assumed (1mg/m1 X-phe 
and 0.4mg/m1 X-trp). 
3.3.4 Isocratic elution 
The poor separation due to the feed has shown once again how important it is to 
keep the feed conditions identical to the initial column conditions. Although 40% 
Me0H feed is better able to solubilize the peptides than 20% Me0H, it gives low 
productivities, and the X-trp could not be isolated. The following runs were done at a 
later time and, as discussed previously, the retention times decreased slightly (See 
section 3.3.2). 92 
The maximum concentration that could be obtained under 20% Me0H was 
around 0.5mg/ml. Under identical feed and inlet column conditions, a 20% isocratic 
Me0H run showed two well-separated peaks except for some tailing of X-phe tailing 
into X-trp (Figure 3.53). Just as in the cases with 40% feeds, the probable cause of the 
tailing is the solubility of X-phe. The 0.5mg/m1 feed concentration of the dipeptide 
mixtures is at the limit of X-phe solubility. The X-phe may have precipitated and 
resolubilized during the run which would have caused it to elute at the same time as the 
X-trp tail. 
A 25% isocratic run showed mixing between the feed bands (Figure 3.54). 
The isocratic 20% was separated enough to allowan increase in the feed volume 
injected. Increasing the volume to 2.4m1 showed that a large amount of X-phe is held 
back by the X-trp, as X-phe tails into X-trp (Figure 3.55). This separation could be 
used to obtain X-phe but because of the tailing of X-phe into the X-trp, the latter 
cannot be isolated at the desired 95 or 98% purity. The productivities show that to use 
the isocratic elutions to purify the X-trp peptide requires using the lower feed volume 
of 0.5ml (Table 3.9). 
Because the column changed retention over time, the effect of the 40% feed was 
re-examined for comparison purposes with the productivities of the preparative isocratic 
20% run. Using a 40% Me0H feed with 1 mg/m1 peptide mixture, the shallow region at 
the front of the peaks can be seen for both peaks (Figure 3.56). If the TFA is removed 
from the peak, the shallow region is accentuated for the X-phe case, and the X-trp peak 
forms a plateau and is about to form a double peak (Figure 3.57). The lack of TFA once 93 
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Figure 3.53: Isocratic 20/80/0.1 Me0H/H20/TFA. 0.4mg/m1Xphe and 0.4mg/m1 
Xtrp in lml feed volume. H2O and TFA throughout, Novapak C-18 column (150 x 
3.9mm I.D.), UV detection at 214nm. 
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Figure 3.54: Isocratic 25/75/0.1 Me0H/H20/TFA. 0.5mg/m1Xphe and 0.5mg/m1 
Xtrp in lml feed volume. All other conditions identical to Figure 3.53. 94 
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Figure 3.55: Isocratic 20/80/0.1 Me0H/H20/TFA. 0.5mg/m1Xphe and 0.5mg/m1 
X --trp in 2.4m1 feed volume. All other conditions identical to Figure 3.53. 
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Figure 3.56: Me0H. Isocratic 20% 1mg/m1X-phe and  lmg/m1Xtrp, 0.5 ml feed 
volume. 40/60/0.1 Me0H/H20/TFA. All other conditions identical to Figure 3.53. 95 
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Figure 3.57: Isocratic 20% Me0H. lmg/m1Xphe and lmg/m1Xtrp, 0.5m1  feed 
volume. No TFA present in the feed. All other conditions identical to Figure 3.39. 
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Figure 3.58: Isocratic 20% Me0H. lmg/m1Xphe and lmg/m1Xtrp, 0.5m1 feed 
volume, 35% feed, no TFA in feed. All other conditions identical to Figure 3.39 96 
again adds to the 40% feed effect. Decreasing the Me0H level slightly in the feed to 
35% resulted in the shallow region at the front of the Xphe to disappear, as well as the 
plateau of the Xtrp peak (Figure 3.58). This run gave a slightly higher productivity 
than the lml run with the 0.5mg/ml mixture with equal feed and inlet column conditions 
(Table 3.9), despite the lower yield of the 35% feed run. Nevertheless the best 
productivity was achieved by the isocratic 20% at 2.4m1 feed volume. 
3.3.5 Gradient elution 
Isocratic 20% at a 2.4m1 volume gave the highest productivity. The Xtrp 
however could only be purified at lower feed volume (0.5m1 volume). A 20-45% curve 
8 gradient in 20 minutes showed a similar separation as to the isocratic run (Figure 
3.59). Although the concentrations were not greater than in the feed, the initial attempts 
seem slightly better than the isocratic 20% run. The mixing, however, is similar to that 
in the isocratic run. Increasing the gradient time to 30 minutes brought about a slightly 
better separation, but the peaks were diluted (Figure 3.60). Tailing remained despite the 
low concentration being used in the feed; however, the separation was better due to the 
absence of the 40% feed. 
Using a linear gradient, and increase in volume to 2.4m1 volume resulted in 
Xphe mixing with Xtrp. The Xtrp peak shape deformed, and the Xtrp peak did not 
concentrate (Figure 3.61). This phenomenon may be explained by the selectivity Description 
X-'Phe 
98% 
Yield  Enrich.  Product. 
95% 
Yield  Enrich.  Product. 
X-trp 
98% 
Yield  Enrich.  Product. 
95% 
Yield  Enrich.  Product. 
isocratic 20%, 
0.4 mg/ml X-phe 
(%) 
99  0.2 
mg/mlhr 
1.32 
(%) 
99  0.2 
mg/mlhr 
1.32 
(%) 
0  0 
mg/ml.hr 
0 
(%) 
99  0.16 
mg/mlhr 
1.08 
0.4mg/m1X-trp 
1.0 ml volume 
isocratic 25%, 
0.5mg/m1X-phe 
71  0.47  1.86  79  0.45  2.04  0  0  0  0  0  0 
0.5mg/m1X4trp 
1.0m1 volume 
isocratic 20%, 
0.5mg,/m1X-phe 
81  0.22  3.36  84  0.22  3.48  0  0  0  0  0  0 
0.5mg/m1X-trp 
2.4m1 volume 
isocratic 20%, 
1 mg/m1 X-phe 
90  0.27  1.6  90  0.27  1.6  0  0  0  64  0.083  1.2 
lmg/m1 X -trp 
0.5m1 volume 
35% feed (no TFA) 
Table 3.9: Yields enrichments and productivities of isocratic preparative runs in Me0H. 98 
reversal effect. The points of the intersection of the selectivity reversal can vary 
according to the concentration of the solute and that of the organic. At low adsorbate 
concentrations, the retention plots are a reasonable approximation of the peptides' 
binding affinity. However, at much higher loadings, the adsorption isotherms become 
non-linear, meaning that the binding of the adsorbates becomes non-linear. Their 
retentions are then strongly dependent on the multicomponent binding of other 
adsorbates as well as the binding of the modulator. The point of intersection of the 
selectivity reversal plots may as a result change according concentration of adsorbates 
are present. For instance, a low concentration of 0.1mg/m1 was used in the adsorbate 
retention graphs (Figure 3.35). At 0.5 mg/ml initial conditions, the selectivity reversal 
point may be lower or higher than that of the adsorbate retention using 0.lmg/ml. In 
Figure 3.61, if we assume that because of high concentration conditions (due in part to 
the large feed injection volume), the point of intersection of the selectivity reversal 
occurs at a lower level, then in high gradient concentration, this would allow some of 
the Xtrp to catch up to the Xphe, thereby diluting its original peak. Some of the 
Xphe on the other hand will loose ground and the tailing of the Xphe occurs. 
Lowering the gradient to 30% Me0H, which is lower than the point of 
intersection of selectivity reversal, results in a good separation (Figure 3.62). In fact the 
productivities are highest for these runs. 
The point of intersection of the selectivity reversal was around 40%. A gradient 
of 30-50% Me0H was done to try to capture the effect of selectivity reversal.  Such a 
gradient would cause the Xphe to initially elute first, until the modulator level is 99 
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Figure 3.59: Curved no. 8 Me0H gradient 20 to 45% in 20min, 0.4mg/m1Xphe and 
0.4mg/m1Xtrp in lml feed volume. H2O and TFA throughout, Novapak C-18 column, 
UV detection at 214nm. 
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Figure 3.60: Curved no. 8 Me0H gradient 20-45 in 30min, 0.4mg/m1Xphe and 
0.4mg/m1Xtrp lml feed volume. All other conditions identical to Figure 3.59. 
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Figure 3.61: Linear Me0H gradient 20-45% in 20min, 0.4mg/m1 Xphe and 0.4 mg/ml 
Xtrp in 2.4m1 feed volume. All other conditions identical to Figure 3.59. 
0.45 
0.4 
0.35 
f 
0.3 -
E 
0 0 
0.25 -
0.2 -
0.15 -
X phe
X trp 
0.1 -
0.05 -
0 
0  5  10  15  20  25  30  35 
Time (min) 
Figure 3.62: Linear Me0H gradient 20-30-30% in 25min, 0.4mg/m1Xphe and 
0.8mg/m1Xtrp in lml feed volume. All other conditions identical to Figure 3.59. 101 
reached such that Xtrp starts to elute faster, causing Xphe peak to be found on both 
ends of the Xtrp peak. However, this reversal effect was not observed (Figure 3.63). 
The isocratic runs gave better productivities in all cases for the purification of 
Xphe (Table 3.10). However, for the purification of Xtrp, the 20-30% ACN linear 
gradient gave productivities that were better than the best isocratic run. However, no 
enrichment occurred for all the runs. The selectivity reversal had a limiting effect on the 
use of the gradient. Nevertheless, Xtrp could be purified better with the gradient than 
with the isocratic. 
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Figure 3.63: Linear Me0H gradient 30-50% in 10min, 0.8 mg/ml Xphe and Xtrp in 1 
ml volume. All other conditions identical to Figure 3.59. Description 
isocratic 20%, 
0.4 mg/ml X-phe 
0.4mg/m1X-trp 
1.0 ml volume 
isocratic 20%, 
0.5mg/m1X-phe 
0.5mg/m1X-trp 
2.4ml volume 
gradient 20-45 
in 30min (c8), 
0.4 mg/m1X-phe 
0.4 mg/ml X-trp 
1.0 ml volume 
gradient 20-45 
in 30min (c8), 
0.4 mg/ml X-phe 
0.4 mg/ml X--trp 
2.4 ml volume 
gradient 20-30-30% 
in 25min, 
0.4mg/m1X-phe 
0.8mg/m1X-trp 
lml volume 
X --phe  X-trp 
98%  95%  98%  95% 
yield  Enrich.  Product.  yield  Enrich.  Product.  yield  Enrich.  Product.  yield  Enrich.  Product. (%)  mg/mlhr  ( %)  mg/mlhr  (%)  mg/mlhr  (%)  mg/mlhr
99  0.2  1.32  99  0.2  1.32  0  0  0  99  0.16  1.08 
81  0.22  3.36  84  0.22  3.48  0  0  0  0  0  0 
94  0.24  0.96  94  0.24  0.96  0  0  0  93  0.2  0.84 
73  0.30  2.4  73  0.30  2.4  0  0  0  0  0  0 
91  0.29  0.9  93  0.27  0.9  0  0  0  100  0.13  1.68 
Table 3.10: Enrichments (enrich.) and productivities (product.) of X-phe and X-trp, for 98% and 95% purity. 103 
4 CONCLUSIONS  
The preparative purification of the chemotactic peptides Xphe and Xtrp was a 
difficult process. Using ACN conditions, there were many factors that made this a 
difficult separation: solubility, convergence of adsorbate retentions, low separation 
factors, and non-linear adsorbate retentions. The Me0H conditions had an added 
complication, that of selectivity reversal. The importance of having the same feed 
conditions as starting column conditions cannot be over-emphasized, and has been 
shown with the various 40% feed preparative runs. 
Under Me0H conditions, the gradient proved not to be beneficial, and was 
unable to concentrate the peaks. However, the Xtrp could be isolated better than under 
isocratic conditions. In addition, a better understanding of selectivity reversal was 
achieved. 
Nevertheless, using an ACN gradient, the peptides could be enriched to twice its 
concentration and productivities of 6mg/m1 *hr were obtained for both peptides (see 
Table 3.7, section 3.26). Although the isocratic run could even produced almost 
7mg/ml*hr, the fractions were not enriched. Furthermore, the cycle time added to the 
isocratic runs was less than that added to the gradient runs, thereby giving a higher 
productivity value for the isocratic runs. 
If it were not for the limit of solubility of Xphe, the volume or concentration 
injected could be increased further, and simulations show that the competitive effects 
would allow much greater enrichments and concentrations, without much increase in 104 
mixing. This is shown by a simulation using a 5m1 feel volume (Figure 4.1). 
Using experimental parameters, the simulation showed that the peaks could be 
concentrated to much higher levels, especially the X-phe peak. The simulation 
considered a Langmuirian feed-feed competitive interactions. A split of the second peak 
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Figure 4.1: Simulation of 10-40% ACN gradient in 20min with 0.71mg/m1 X-phe and 
0.68mg/m1 X-trp in 5m1 feed volume (Velayudhan 1997). 
and the tailing of X-phe tails into the X-trp peak were present. This reduces the yield of 
both X-phe and X-trp. However, it is commonly known that despite the lower yields, 
the productivity can be much higher in nonlinear preparative chromatography due to the 
concentration of the fractions (Guiochon 1986). 
In Table 3.8 (section 3.2.6), the 10-40% gradient at 2.4m1 volume gives an 105 
enrichment of 1.9. However, interestingly, the 3.0m1 volume only gives an enrichment 
of 2.1. The increase in enrichment is small relative to the increase in the volume. This is 
probably due to self interference adsorbate behavior occurs in the non-linear region of 
their SCI. At such high loading, gradient linearization is no longer valid, and the peak 
focusing effect is overcome by non-linear peptide interactions. Although ideally one 
would want to use the focusing effect to achieve tremendously high enrichments, in this 
case, the self-interference of the peptides was beneficial to this separation, because it 
prevented Xphe from falling out of solution. 
These preparative runs have shown the potential of overloaded gradient elution 
as a method for preparative separations. Additional work could be done on ternary 
mixtures to purify the middle compounds, assuming the other two mixtures are 
impurities. The high loadings in this study was limited by solubility. Studies using high 
feed concentrations where no solubility limits exist, such as amino acid purifications 
could be examined. 
There will always be purification challenges when dealing with biomolecules 
because of their inherent biological complexity such as solubility, denaturation, etc. 
However, the potential for non-linear gradient elution offers chromatographers an 
additional tool to overcome these challenges. 106 
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APPENDIX A  
Qbasic program for isotherm calculations 
' Isotherm Calculations 
DIM SHARED t(200), c(200), q(200) AS DOUBLE 
DIM SHARED n AS INTEGER 
INPUT "filename where data is stored :"; isodata$ 
isofile$ = "flhome/lcimbi/research/traces/isotherm/isomeohr + isodata$ 
PRINT isofile$ 
'first store data in arrays t and c 
OPEN isofile$ FOR INPUT AS #1 
n = 0 
DO WHILE NOT EOF(1) 
n = n + 1  
INPUT #1, t(n)  
INPUT #1, c(n)  
PRINT t(n), c(n)  
LOOP 
CLOSE #1 
'next, calculate isotherms 
INPUT "Feed volume being injected: "; Vinj 
sum = 0 
Vo = 1.19  'dead volume 
Vs = .602  'solid volume 
PRINT "C", "q" 
P = n 
FOR i = 1 TOP 
sum = c(n) + sum  
q(n) = sum * .25 + c(n) * (t(n) Vo - Vinj)  
q(n) = q(n) / Vs  
PRINT c(n), q(n)  
n = n - 1  
NEXT i 
'finally store in file 
INPUT "filename where q values can be stored :"; isodata$ 
isofile$ = "flhome/lcimbi/research/traces/isotherm/isomeohr + isodata$ 
OPEN isofile$ FOR OUTPUT AS #2 
FOR i = 1 TOP  
PRINT #2, c(i), ",", q(i)  
NEXT i  
END 115 
APPENDIX B 
Plate count 
Plate count is a measure of the efficiency of the column. It is used in the 
simulations for the determination of the plate height (H). From an analytical 
chromatogram of a sample of dipeptides run under isocratic elution, the plate count may 
be determined using the equations listed in Table B.1. 
Equation  description of variables 
wb is the width at half height  1 
N 554( = 
tR 
)2  tR is the retention time  
Wh 
2  wb is the width of the intersection of the tangents to the t 
N =16(L-)2  inflection points of the curves  
wb   tR is the retention time 
3  t  These are for asymmetrical peaks. A and B represent the  
41.7(  R  )  width for each side at 10% of the total height. 
A+ B N =  tR is the retention time  
B +1.25  
A  
4  Using the rate theory, the variables can be obtained  t
N = (-? )2 numerically. a  
itcdt  
tR  = IA, = 
0  
fcdt  
0 
co 
f(t  t R)2 Cdt 
2  / 0 
a r = Vt2  = 
fcdt 
0 
Table B.1: Summary of equations used for plate count determination 116 
The plate counts of the Novapak C-18 (150 x 3.9mm I.D.) are given in Table 
B.2. There is some asymmetry in the peaks, which causes the numbers in the last 
column to be somewhat lower than the other entries. Nevertheless these results show 
that this is an efficient column. 
2  t 2  tR N = 5.54(t  )  N =16(  -)  41.7(  )2 
vvi,  W h  A + B N = 
B +1.25 
A 
Trial 1 Xphe  2990  2640  2314  
Trial 2 Xphe  3350  2770  2428  
Trial 1 Xtrp  4180  4060  2870  
Trial 2 Xtrp  4057  3680  2330  
Table B.2 : Plate counts of Novapak C-18 column for Xphe and X.trp for efficiency 
determination. 117 
APPENDIX C  
Error distribution, summary of raw data 
Date  X-phe mass in  X-phe mass out % error  X-trp mass in  X-trp mass out  % error 
mg mg  mg  mg 
9/16/96  1.776  1.953  10.0  1.704  1.8795  10.3 
7/23/96  0.051  0.055  7.8  0.64  0.746  16.6 
7/25/96  0.48  0.501  4.4  0.37  0.396  7.0 
8/1/96  0.5  0.505  1.0  0.38  0.459  20.8 
8/1/96  0.58  0.578  -0.3  0.41  0.452  10.2 
8/5/96  0.09  0.081  -10.0  0.42  0.565  34.5 
8/6/96  0.34  0.364  7.1  0.43  0.562  30.7 
9/5/96  0.36  0.367  1.9  0.47  0.605  28.7 
9/10/96  0.715  0.774  8.3  0.73  0.782  7.1 
9/11/96  0.54  0.596  10.4  0.545  0.611  12.1 
9/12/96  1.79  1.94  8.4  1.84  2.05  11.4 
10/3/96  2.19  2.36  7.8  2.16  2.47  14.4 
10/8/96  1.728  1.832  6.0  1.67  1.77  6.0 
10/10/96  1.8  1.797  -0.2  1.8  1.86  3.3 
10/29/96  2.19  2  -8.7  2.16  2.29  6.0 
2/27/96  0.459  0.554  20.7  0.605  0.811  34.0 
2/29/96  0.899  0.91  1.2  1.19  1.04  -12.6 
3/6/96  0.94  0.934  -0.6  0.86  1  16.3 
3/7/96  0.47  0.45  -4.3  0.43  0.47  9.3 
3/14/96  0.57  0.479  -16.0  0.515  0.41  -20.4 
3/20/96  0.565  0.517  -8.5  0.49  0.464  -5.3 
4/3/96  0.465  0.482  3.7  0.485  0.454  -6.4 
4/4/96  0.555  0.505  -9.0  0.495  0.464  -6.3 
4/5/96  0.575  0.54  -6.1  0.495  0.463  -6.5 
4/8/96  0.525  0.483  -8.0  0.5  0.447  -10.6 
4/15/96  0.515  0.485  -5.8  0.535  0.46  -14.0 
4/17/96  0.635  0.571  -10.1  0.67  0.553  -17.5 
4/18/96  0.192  0.192  0.0  0.545  0.545  0.0 
4/25/96  0.245  0.221  -9.8  0.51  0.49  -3.9 
4/30/96  0.585  0.542  -7.4  0.22  0.189  -14.1 
5/2/96  0.585  0.527  -9.9  0.21  0.186  -11.4 
5/7/96  0.265  0.235  -11.3  0.53  0.472  -10.9 
11/7/96  0.41  0.423  3.2  0.41  0.43  4.9 118 
Error distribution, summary of raw data (continued) 
Date  X-phe mass in  X-phe mass out % error  X-trp mass in  X-trp mass out  % error 
mg mg  mg mg 
11/11/96  0.41  0.427  4.1  0.39  0.4  2.6 
11/13/96  0.54  0.536  -0.7  0.53  0.561  5.8 
11/15/96  0.525  0.535  1.9  0.515  0.546  6.0 
11/19/96  1.176  1.216  3.4  1.08  1.08  0.0 
11/21/96  0.39  0.374  -4.1  0.76  0.774  1.8 
11/25/96  1.2  1.24  3.3  1.2  1.263  5.3 
12/3/96  0.495  0.478  -3.4  0.545  0.51  -6.4 
12/4/96  0.455  0.494  8.6  0.43  0.469  9.1 
12/9/96  0.435  0.519  19.3  0.18  0.212  17.8 
3/12/96  1.06  0.994  -6.2 
4/9/96  0.31  0.229  -26.1 
4/9/96  0.715  0.583  -18.5 
4/12/96  0.176  0.164  -6.8 
4/12/96  0.265  0.25  -5.7 
6/6/96  0.43  0.431  0.2 
6/11/96  0.305  0.323  5.9 
6/13/96  0.77  0.796  3.4 
6/17/96  1.74  1.85  6.3 
6/18/96  0.8  0.819  2.4 
6/21/96  0.118  0.142  20.3 
6/24/96  0.49  0.518  5.7 
7/1/96  6.72  6.8  1.2 
9/18/96  2.21  2.45  10.9 
9/19/96  1.09  1.23  12.8 
1/15/97  7.27  6.94  -4.5 
1/16/97  1.73  1.86  7.5 
average X-phe error = 0.0184 
standard deviation X-phe = 8.9997 
average X-'phe error = 3.6719 
standard deviation X --trp =12.799 